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ABSTRACT OF THE DISSERTATION

Bis(Tryptophan) Amphiphiles: Design, Synthesis and Efficacy as
Antimicrobial Agents
by

Michael McKeever
Doctor of Philosophy in Chemistry
University of Missouri – St. Louis, 2022
Dr. George W. Gokel, Advisor

Amphiphiles play important roles in nature. These molecules contain both
hydrophilic and hydrophobic regions, leading to some astonishing properties. The
lipid bilayer of the cell membrane is a fascinating organization of amphiphilic
phospholipids. Natural and synthetic amphiphiles, such as antimicrobial peptides,
are known to interact with the cell membrane. Such interactions can impact
transport of molecules across the cell membrane, disrupting cell functions. In this
work, a library of tryptophan-containing amphiphiles was synthesized and their
antimicrobial properties were explored.

First, a library of bis(tryptophan) amphiphiles was synthesized. Preparation
included a coupling reaction of a diamine with tryptophan residues, via the
carboxy-termini of the amino acids, at either end. The carbon chain length of the
diamine was varied to yield bis(tryptophan) amphiphiles of varying lengths.
Traditional methods of characterization, including NMR, mass-spectrometry, and
melting-point determination, were used to confirm identification of the compounds
ii

synthesized. The alkylene linker chains varied from 3-14 carbons in length.

Second, the antimicrobial activity of the bis(tryptophan) amphiphiles was
explored. Minimum inhibitory concentrations (MICS) were determined for each of
the amphiphiles against three bacterial strains. E. coli (K-12) was used for the
initial screening, followed by a methicillin-resistant S. aureus (MRSA) strain and
then a multi-drug resistant (MDR) strain of E. coli. Biological activity was
observed for four of the amphiphiles in the micromolar range. The C14BT
[(CH2)14(L-Trp)2∙2HCl] was the most potent of the amphiphiles against both E.
coli and S. aureus.

Third, characterization of the properties of the bis(tryptophan) amphiphiles was
conducted. Dynamic light scattering studies showed that some of the
amphiphiles formed aggregates in phosphate buffered saline solution. The
amphiphiles that did not form aggregates were also not biologically active against
any of the three bacterial strains. Scanning electron microscopy confirmed the
presence of spherical aggregates > 1000 nm in diameter.

This work has allowed for the development of more potent bis(tryptophan)
amphiphiles. It has shown their ability to form aggregates in saline solution and
demonstrated a link between antimicrobial activity and aggregate formation.
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Chapter 1
Introduction and Background
1.1

Amphiphiles and Membranes
1.1.1

Cell Membranes. Cellular membranes are complex and varied

structures seen throughout nature in living organisms. The fluid-mosaic model of
the cell membrane structure was developed by Singer and Nicolson in 1972. [1]

Figure 1.1 Schematic representation of the fluid-mosaic model of
a cell membrane as depicted by J. Lombard. [2]

In his work in 2014, Lombard describes the fluid mosaic model as the
agreed upon model for cell membranes in modern day science. [2] As seen in
Fig. 1.1, the membrane consists primarily of a lipid bilayer with many
carbohydrates and proteins protruding into or through the fatty layers. The main
components of the lipid bilayer are phospholipids. These molecules are
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described as being amphipathic or amphiphilic molecules. They are composed of
a polar “head” group (hydrophilic) and an apolar tail (hydrophobic). The molecule
is arranged such that the “water-loving” head groups are interacting with the
water molecules and the hydrophobic tails are facing each other. [1] [2]
Cell membranes have a vast array of functions including exerting control
over which substances enter and leave the cell. This allows the cell to maintain
ion homeostasis, which is essential for cell survival. Low molecular weight
hydrophobic molecules along with small uncharged molecules, such as O 2 and
CO2 can pass through the membrane unaided, as can some small molecule
drugs and waste products, such as urea. [3] Larger molecules and ions are
transported across the cell membrane via specialized proteins, such as
aquaporins, a type of integral protein which facilitates the transport of water
molecules across the cell membrane. [4]
The ability of cell membranes to control substances entering and leaving
the cell also serves as a defense mechanism. If substances that are toxic to the
cell cannot cross the cell membrane, either with or without the use of membrane
proteins, then the toxin cannot impact the cell functions. If the toxin is capable of
passing into the cell, but the cell is very efficient at removing the toxin from the
cell, perhaps by the use of specialized proteins, then the cell can protect itself
from the toxin having a high enough concentration within the cell, or enough time,
to impact the cell functions. Compartmentalized cell types (cells with a cell
membrane) are diverse and many have developed self-defense mechanisms that
are much more complex and beyond the scope of this research, however all start
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with the presence of a cell membrane. [5]
As this research will be concerned with the cell membranes of bacterial
cells specifically, it is important to note two of the main bacteria cell types and to
look at their cell membranes comparatively and contrastively.

Figure 1.2 Schematic representation of Gram-positive and
Gram-negative cell envelopes: CAP = covalently attached
protein; IMP, integral membrane protein; LP, lipoprotein;
LPS, lipopolysaccharide; LTA, lipoteichoic acid; OMP, outer
membrane protein; WTA, wall teichoic acid [6]

The two major groups of bacterial cell types are Gram-positive and Gramnegative bacteria, the cell envelopes of which are depicted in Fig. 1.2. [6] As can
be seen in the diagram, the Gram-negative cell envelope has three distinct
components: the outer membrane, the periplasmic space, which also contains
the peptidoglycan layer, and the inner cell membrane. Contrastively to this, the
Gram-positive bacteria lack an outer membrane in their cell structure. The outer
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membrane is a significant defense mechanism for the Gram-negative bacteria
and also, indirectly, helps stabilize the inner membrane of the Gram-negative cell
envelope. This added stabilization decreases the need for a thicker
peptidoglycan layer within the Gram-negative bacterial envelope and so a much
thinner peptidoglycan layer is observed than in the Gram-positive structure. The
thicker peptidoglycan layer in Gram-positive bacteria provides extra protection to
the bacteria since they lack an outer membrane. Turgor pressure experienced
from many of the environments where bacteria exist can also be tolerated due to
the presence of an outer membrane (Gram-negative) or much thicker
peptidoglycan layers (Gram-positive). The other components of the cell
envelopes, such as the proteins and carbohydrates anchored in the membrane
or peptidoglycan layer, vary greatly and can be influenced by specific cell type,
function and the environment in which they exist. [6]

1.1.2

Amphiphiles in Nature. The word amphiphile became the popular

term to describe a molecule having both a hydrophilic and hydrophobic region,
around the middle of the 20th century. [1] These molecules are important
throughout nature having the ability to form thermodynamically stable aggregates
of varying shapes and orientations. The shape and size of the aggregates formed
vary significantly as can be seen in Fig. 1.3. [7]
The conditions of the solution in which the amphiphile is present will influence
the shape and size of the aggregates. The pH, temperature and ionic strength of
the solution can all have an impact on the formation of the aggregates. The
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overall determining factor, however, is the geometry of the component
amphiphilic molecules. The morphology of the resulting aggregate most
commonly will be a spherical or cylindrical micelle, a bilayer vesicle, lamellar
(such as a bilayer membrane) or an inverted micelle. [7]
Israelachvili determined that the morphology of the aggregates could be
predicted using the critical-packing factor (Cpp). [7] [8]

Cpp = V0 / AmicIc

In this equation, V0 is the volume taken up by the hydrophobic chains in
the core of the aggregate, Amic is the effective surface area of the hydrophilic
headgroup at the aggregate-solution interface, and Ic is the critical chain length
(maximum effective length of the chain). The aggregates with the smallest Cpp
value (Cpp < 1/3) are spherical aggregates. With an increase in Cpp value,
cylindrical aggregates are formed (1/3 < Cpp < ½). Vesicles with an internal cavity
will be formed when the Cpp value is larger than ½ but less than 1 (½ < Cpp < 1).
When the Cpp value is 1, lamellar aggregates are observed. When the critical
packing parameter is greater than one, inverted micelles are formed. In this type
of aggregate, the hydrophilic head groups are clustered around an aqueous
solvent with the hydrophobic tails radiating outwards, in the opposite direction. [8]
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Figure 1.3 Diagram showing the impact of Cpp values and
shape of component amphiphilic molecule on the overall
shape of the aggregates formed. Reproduced from
reference [7]
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Undoubtedly, one of the most common and well-known amphiphilic
aggregates occurring in nature is the bilayer membrane. There are many other
amphiphilic aggregations seen throughout nature, some of which can be
problematic for human survival, such as ß-amyloid (Aß) proteins that are linked
to Alzheimer’s Disease (AD). It is known that amyloid protein deposits in tissues
can cause cell death and they are linked to numerous other diseases in addition
to AD. [9] The various disease-causing amyloids may contain different proteins,
however they all have the characteristic ß-sheet conformation. It was believed
that the shared secondary structure was responsible for the mechanism causing
cellular toxicity. No obvious connection between the sequence of amino acids
forming the secondary structure was observed in the toxic amyloid proteins. It is
understood that the Aß causes over-accumulation of H2O2, leading to lipid
peroxidation and finally, cell death. Until recently, it was unknown that the
presence of ß-sheets alone was not responsible. It has been shown that it is the
amphiphilic nature of the peptides produced by the ß sheets and not merely the
presence of ß sheets, that causes the amyloid toxicity. [9] [10]
Amphiphiles often perform functions that are advantageous to the cells and
organism. Antimicrobial peptides (AMPs) are short chain peptides produced by
most living organisms. In single cell organisms they assist the cell in competing
for essential nutrients, whereas in multicellular organisms, they form an important
component of the innate immune system. [11] AMPs have been around for a very
long time and are very effective at killing bacteria, including antibiotic-resistant
bacteria. Their non-specific mechanisms of action have allowed for very little
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resistance to be developed against these compounds. The design of synthetic
amphiphiles mimicking these compounds could provide an effective solution to
the antibiotic-resistance issue that is becoming more concerning each day. [11]

1.1.3

Synthetic Amphiphiles. As seen in nature, amphiphiles are

essential for life (e.g. cellular membranes) [2] and can be advantageous in
numerous other ways, perhaps most importantly as antimicrobial agents. [11]
One well-known class of synthetic amphiphiles is pepducins. These
lipopeptide compounds have shown the ability to modulate the transference of
signal from receptors to G proteins, inside the cell. G protein-coupled receptors
are essential for a number of cell functions including cell growth and metabolism,
blood coagulation, and neuronal signaling. [12] For example, the peptide
palmitoyl-LysLysSerArgAlaLeuPhe, which is known to inhibit platelet
aggregation. Several other biological properties have also been confirmed for this
compound.
In the 1990’s, there was considerable development and utilization of
various types of liposomes. Drug loading and delivery methods were optimized
by utilizing ion gradients with polymorphic liposomes. Chemotherapy also
benefited from the development of “stealth” liposomes, so called because of their
reduced recognition by the immune system. [13] In the mid-20th century, the
formation of vesicles was achieved using the phospholipid, dipalmitoyl lecithin,
however, during the 1970’s, Kunitake and Okahata developed a method to
produce a fully synthetic bilayer membrane using didodecyldimethylammonium
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bromide [(C12H25)2N+(CH3)2 Br¯], a double-chained surfactant. [14] This new
method made synthesis of liposomes much easier and so the interest in,
development of and application of synthetic amphiphiles grew exponentially over
the following decades. [15]
During the next few decades, the exploration of synthetic amphiphiles and
their potential within healthcare was explored extensively, and this exploration
still continues. There has been much success in the areas of gene therapy, drug
targeting, drug development, and antibacterial treatment. [16]

1.1.4

Amphiphiles in the Gokel Lab. At the beginning of the 21st century,

considerable attention in the wider community was being given to the
development and characterization of synthetic anion transporters (SATs) and
synthetic ion channels. [17] [18] At this time, the Gokel lab was also making
significant progress and discoveries in this area. In the late 2000’s, the Gokel
group used their work with SATs to explore the aggregation behavior and
molecular organization of amphiphiles at the membrane / aqueous interface of
cells. The molecular dynamics surrounding membrane insertion and, more
generally, the organization and aggregation of amphiphiles, had not been
explored until this point. [19] As part of this work involving the SATs, eleven
different amphiphilic compounds, comprising amino acids, were studied. The
structures of these amphiphiles are shown in Fig. 1.4.
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Figure 1.4 Structures of 11 amphiphiles explored in the SAT
series of compounds. [19]

A range of techniques was used during this study, including Langmuir
trough studies and Brewster angle microscopy (BAM) to determine the
organization and stability of aggregates at the air-water interface. Dynamic light
scattering (DLS) studies and transmission electron microscopy confirmed the
results of the Langmuir trough and BAM studies and also defined how SATs
aggregated and behaved in solution. Overall, the study found that when
compounds formed stable monolayers at the air-water interface, they also formed
spherical aggregates in solution. This study also found that transport of anions
was more effective by amphiphiles that formed less-stable monolayers. Less
stable amphiphiles are able to join with other amphiphiles in the membrane layer
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and form a pore for the anions to pass through. If the amphiphiles are too stable,
they may not readily form pores and so are less effective at anion transport. [19]
The work on synthetic amphiphiles in the Gokel lab also included the
creation and development of a class of compounds known as “hydraphiles.”
These molecules are comprised of three crown ether macrocycles connected
together by spacer chains of varying length. One of the hydraphiles synthesized
by the lab is shown in Fig. 1.5. [20]

Figure 1.5 Structure of a hydraphile molecule, created by the Gokel lab [20]

The hydraphiles were designed to function as ion channels in bilayer
membranes. This ability was extensively documented. These compounds also
have shown much success as antimicrobial agents. They are capable of inserting
into bilayer membranes and conducting the transport of ions. This allows for a
disruption of ion homeostasis. This, of course, is inimical to the cellular function
of bacteria, but also shows activity against yeast and even mammalian cells.
Planar bilayer conductance studies have shown that these molecules mimic
protein channels and exhibit open-close behavior once inserted into the bilayer
membrane. The non-rectifying mechanism of action engenders toxicity to
11

bacteria and yeast. Lower levels of toxicity were observed towards mammalian
cells, probably because the hydraphile’s nitrogen atoms are protonated at
physiological pH and are thus attracted to negative bacterial surfaces. Even so,
an option is to co-administer hydraphiles at concentrations below their toxic
threshold with an antimicrobial drug. Studies have shown that the hydraphiles
can enhance antibiotic potency at such concentrations, presumably by enhancing
membrane permeability, and therefore show potential as adjuvants. [20] [21]
Before the development of the hydraphiles, the Gokel lab also developed
lariat ether amphiphiles and identified various applications for them. The general
structure of the lariat ethers is similar to that of hydraphiles in that a crown ether
macrocycle is employed. Initially, the lariat ethers were developed having donor
group-containing side arms attached to the macrocycle. Recently developed
lariat ethers had an n-alkyl side chain attached to either side of the crown ether
macrocycle. The general structure of the lariat ether amphiphiles can be seen in
Fig. 1.6. [22] [23]

Figure 1.6 Structures of a lariat ether molecule having side arm donors (left) and a
general structure of dialkyl lariat ether molecules [22]
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The lariat ethers were initially designed as ion carrier molecules. The side
arms wrapped around a ring-bound cation and provided solvation so the cation
could be transported across bilayer membranes. In more recent times, the
removal of the donor group coincided with the discovery of the ability of n-alkyl
lariat ethers to form pores through which ions could be transported. At this time, it
was also discovered by the Gokel lab that lariat ethers could enhance the
potency of antibiotics, when they were co-administered to bacteria. In 2016, the
Gokel lab showed that the administration of non-toxic levels of dialkyl lariat
ethers could improve the potency of both rifampicin and tetracycline against two
strains of E. coli. [22] [23]
Following the success of the Gokel lab in developing amphiphiles with
antimicrobial activity, the group explored another family of compounds, the
bis(amino acid) amphiphiles. [23] Firstly, the group focused on bis(tryptophan)
amphiphiles (BTs), noting that indole groups may behave as anchors in the
membrane [24] and that tryptophan residues appear only near the membrane
boundaries in most peptides and proteins, such as the KcsA voltage-gated ion
channel. [23] [25] The Gokel group designed a series of BTs with the general
formula H2N-Trp-Y-Trp-NH2 (H2N-W-Y-W-NH2) in which Y is an aryl or alkyl linker
residue. The expectation of these molecules is that the tryptophan indole group
would behave as a membrane anchor and the molecular amphiphile would
enhance membrane permeability. [23] The anticipated effect of the increased cell
membrane permeability was a disruption to ion homeostasis and mechanisms of
antibiotic resistance of the bacterial cell. It was predicted that the BTs might be
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able to display antimicrobial activity through this mechanism of action. [23]
In 2016, the Gokel group screened nine of their tryptophan containing
compounds against a strain of Gram-positive bacteria (S. aureus) and two strains
of the Gram-negative bacteria E. coli. [26] One of the strains tested (E. coli.
TetR), is a bacterial strain developed in the Gokel lab that displays resistance to
tetracycline as it has been engineered to include a tetracycline selective TetA
efflux pump. As expected, the activity of the compounds varied based on the
spacer linker. Five of the BTs were found to be biologically active against both
the Gram-positive and Gram-negative bacteria. All four of the BTs with
phenylene linkers were active, however only one of the BTs with an alkyl chain
linker was active. The active alkyl-linked BT had twelve carbons in the spacer
chain so the formula was H2N-Trp-(CH2)12-Trp-NH2. The results from the
minimum inhibitory concentration (MIC) study can be found in Table 1.1. [26]
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Table 1.1 Minimal Inhibitory Concentrations (MICs) of the various BTs against
the three bacterial strains. [26]

Two controls (meta-Ph (Gly) and meta-Ph (IPA)) were also included.
bStructure of both amino acids. c 3-(3-Indolyl)propanoic acid.

Interestingly, while the phenylene-linked BTs all showed some level of
potency against all three bacterial strains, the orientation of substitution on the
arene made a significant difference to the activity of the molecule. The C12BT
(H2N-Trp-(CH2)12-Trp-NH2) was the only active alkyl-linked BT and was the most
active compound overall. This suggests that the length of the spacer chain, and
perhaps the hydrophobicity of the linker also, are important for the activity of the
amphiphile. [26]
At the same time, these compounds were studied for their efficacy to
reverse tetracycline resistance in E. coli. It was revealed that at subinhibitory
concentrations, a number of the BTs were able to recover the antibacterial
15

activity of tetracycline against the TetR E. coli. [26] The meta-Ph (L-Trp), meta-Ph
(D-Trp), ortho-Ph (L-Trp), para-Ph (L-Trp), C3BT (H2N-Trp-(CH2)3-Trp-NH2) and
the C12BT (H2N-Trp-(CH2)12-Trp-NH2) all recovered tetracycline potency at ½ MIC
or lower.
Whilst the scope of the antimicrobial activity studies at this time were
limited, they did show that BTs could be toxic to bacterial cells at concentrations
at which there was limited cytotoxicity to mammalian cells. The potential of this
class of amphiphiles was significant, particularly against efflux-pump mediated
resistance in bacteria and the group sought to expand their family of BTs and
explore the potential mechanisms of action and scope of activity further. [26]
Following on from this work, the Gokel lab explored developing other
amino acid derivatives of the BT amphiphiles. The general formula H2N-Aaa-YAaa-NH2 would be used to develop the series further. The group decided to use
the meta- phenylene model (W-mC6H4-W) as their “first pass” screening for
active compounds. This model was chosen for a variety of reasons including the
less complicated isolation of compound during synthesis and the surprising
differences in activity between the D,D- and L,L-isomers of the meta-phenyl BT
(Table 1.1). This difference in activity of isomers would offer potential for further
exploration of the amino acids if any active compounds were developed. [26] The
structures of the compounds synthesized and analyzed can be seen in Fig. 1.7.
[23]

16

Figure 1.7 Structures of the bis(amino acid) compounds having
arene spacers that were synthesized and analyzed. [23]

Compounds 7 and 8 are phenylalanine and tyrosine derivatives,
respectively. They, like tryptophan, have electron-rich aromatic groups and so
may behave similarly. Compounds 9 and 10 are the leucine and alanine
derivatives. They contain simple alkyl groups and so were prepared to
investigate the absence of more electron-rich terminal groups. Compound 11 is a
proline derivative, providing assessment of a compound with a smaller cyclic
terminal group. Threonine is used as the amino acid group in compound 12. Both
compound 12 and compound 8 have hydroxyl groups, and both can accept and
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donate hydrogen bonds. Compound 13 is a lysine derivative and has double the
number of positive charges present compared with the other derivatives. The
variety of the compounds in Fig. 1.7 encompassed a significant range of the
variation observed among the 20 common amino acids. [23]

Table 1.2 Minimum Inhibitory Concentrations (µM) of the amino acid derivatives
and the previously explored BTs against S. aureus and TetR E. coli [23]

Table 1.2 shows the results of the bacterial studies for the amino acid
derivatives, along with data for the previously successful BTs (compounds (1-6))
and five control compounds. None of the amino acid derivatives showed any
activity below 128 µM against either the Gram-positive bacterial strain (S.
aureus) or the tetracycline resistant Gram-negative strain (TetR E. coli). The
absence in activity for this selection of amino acid containing compounds
reinforced the hypothesis that the indole group of the tryptophan is important for
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cell membrane activity of these compounds. [23]
Further work was also carried out with the BTs previously found to be
active against bacteria. Bilayer Lipid Membrane (BLM) studies were conducted,
and traces indicating pore formation obtained for some of the BTs. The D,Disomer of the m-phenyl BT provided the traces (not shown) with greatest
reproducibility. Open-close behavior was observed, and the traces evinced clear
channel activity. The traces alluded to the presence of either two open channels
or aggregation of an unknown number of monomers. Molecular models of the mphenyl BT suggests that the distance between the amino groups is ~ 12Å,
whereas the hydrocarbon section of a bilayer membrane is estimated to be
around 30-35Å. This suggests that a single molecule would be too short to span
a bilayer and so a barrel-stave or toroidal pore may be formed by the amphiphile.
[23]
To investigate the ability of the BTs to penetrate the bacterial membrane
and enhance membrane permeability, the Gokel group conducted bacterial
permeability analysis using fluorescence. Propidium iodide is a popular redfluorescent counterstain for the cell nucleus and other DNA-containing
organelles. It does not pass through the cell membrane of healthy cells under
normal conditions so the presence of propidium iodide inside cells suggests
increased cell membrane permeability. Both L,L- (W) and D,D-isomers (w) of the
m-phenyl BT (W-mPh-W and w-mPh-w) and the L,L-isomer of the C12BT (W-C12W) were investigated against Gram-positive S. aureus cells. [23]
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Figure 1.8 Results of the fluorescence-based cell permeability assay using
propidium iodide for BTs against S. aureus cells. TX100 = Triton X-100
(detergent). RFU = relative fluorescence units. Each bar represents an
average of three independent trials. [23]

As seen in Fig. 1.8, there is no increase in propidium iodide fluorescence
in concentrations of BTs up to and including 2 µM. The L,L-isomer of metaphenylene BT (W-mPh-W) did not appear to have any impact on the measured
fluorescence up to 32 µM, which coincided with the lack of activity of the
compound against S. aureus below 128 µM (Table 1.2). The D,D-isomer (w-mPhw) almost doubled the measured fluorescence at 32 µM, this also matched the
biological data, which showed that the compound was active against S. aureus at
concentrations as low as 16 µM. The alkyl BT W-C12-W increased fluorescence
the most, however, with a 3-fold increase from 4 µM to 32 µM. Furthermore, it is
evident that an increase in fluorescence can be seen from a concentration as low
as 4 µM, again coinciding with the bacterial activity seen above. [23]
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At this point, the Gokel lab had developed a small library of BT compounds
and established potency against both Gram-positive and Gram-negative bacteria,
along with a tetracycline resistant strain of E. coli. There was evidence of cell
membrane activity through both the BLM studies and fluorescence assays that
coincided with the biological activity. Significant work had also been done on
cytotoxicity to mammalian cells that framed the range within which compounds
showed activity against bacterial cells. At this time, the Gokel lab had also
established activity for BTs as adjuvants, which will be discussed later in this
chapter. Further development of the library of BTs and further exploration of the
potential mechanism of action will be the primary focus of this doctoral thesis.
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1.2 Antimicrobial Resistance
1.2.1

Mechanisms of Resistance. Antimicrobial resistance (AMR) is a

serious international concern. Bacteria, yeast, fungi, and viruses have a
remarkable capability of adapting to their environments and overcoming
antimicrobial medications through a variety of mechanisms. The World Health
Organization (WHO) has labeled AMR as one of the top ten leading health crises
facing the human race. [27] As resistance to current medications continues to
develop, the primary concern is the inability to treat emerging “superbugs” which
are so resistant as to be untreatable, with mortal consequences, especially to
those most vulnerable in society. There are also many other concerns about the
continued increase in resistance including, disability, long term illness,
complications to surgery, and cancer treatments. The impact will also be felt
financially from a variety of viewpoints. It is estimated that AMR will be
responsible for around 300 million premature deaths by 2050, costing the global
economy around $100 trillion. [28] Longer hospital stays and expensive
medications will be a financial strain on all those acquiring infections. The cost of
research and development of new medications is also a crucial burden to society.
It is unsurprising that the WHO considers this problem one to be addressed
urgently and one that transcends multiple sectors of medicine and scientific
research. [27]
While the problem of resistance includes various microbials, it would be
beyond the scope of this introduction to discuss each of those in detail. Antibiotic
resistance and the mechanisms which allow bacteria to be resistant are the focus
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of this discussion.
One of the first major breakthroughs in targeting bacterial infections
occurred in 1909. Paul Ehrlich developed a “magic bullet” capable of attacking
Treponema pallidum, the bacterium responsible for causing syphilis infections.
Arsphenamine (Salvarsan) is an arsenic containing compound that proved
effective against T. pallidum (Fig 1.9). Ehrlich’s work helped revolutionize the
fight against bacteria. [29] [30]

Figure 1.9 Structure of arsphenamine, also called
Salvarsan

Since the 1940’s, the name Alexander Fleming has become synonymous with
the term “antibiotic.” Fleming is often considered the father of antibiotic
compounds due to his accidental discovery of the antibiotic ability of a Penicillium
fungus in 1928. Penicillin was then developed for use as an antibiotic in the
late1930s. [31] Other drugs, such as sulfa drugs and quinolones soon followed
as antibiotic agents.
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Although penicillin is thought of as the first successful antimicrobial drug, the
first effective antibiotic drug was the azo dye called prontosil (Fig 1.10). It was
discovered by Gerhand Domagk working in Germany. Prontosil is actually a
prodrug; the active component is sulfanilamide. Domagk won the 1939 Nobel
Prize for this work. Alexander Fleming would not share the Nobel Prize until
1945.

Figure 1.10 Structure of Prontosil

By the end of the 19th century, actinomycetes had already been discovered.
These bacteria naturally produce antibiotic compounds to help them compete for
food and survival in the soil. Although they were used to treat some bacterial
infections at the time, interest was limited, until the discovery of streptomycin in
1943. Streptomycin, which came from the genus Streptomyces, was the first
effective treatment for tuberculosis (TB). [31] During the 20th century, the
development and use of antibiotics accelerated exponentially. Many of the
antibiotics employed were natural compounds, although synthetic analogues and
novel compounds did emerge. With this rapid increase in the use of antibiotics,
resistance seemed to emerge almost as quickly. Several reasons account for
such rapid development of resistance. One is simply overuse and poor antibiotic
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stewardship. The fact that many antibiotics are naturally occurring compounds is
another issue. Bacteria have coexisted for millions of years with the antibiotics
and other antibiotic producing organisms. Some strains are likely to have already
developed resistance to the antibiotics during evolution. It is important, therefore,
that while inspiration may be derived from nature, newly developed compounds
should be novel and target bacterial cells via new mechanisms of action. [32]
To better understand how to overcome antibiotic resistance, it is important to
acknowledge the different mechanisms of resistance. Fig. 1.11 shows the most
prevalent resistance mechanisms observed in bacteria. [33]

Figure 1.11 Representation of the general resistance
mechanisms in bacteria cells, reproduced from AIMS
Microbiology, Vol. 4 [33]
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As mentioned earlier in this chapter, one of the main mechanisms of
resistance is the cell membrane itself, which limits the initial uptake of the drug
molecules. If the compound cannot penetrate the cell membrane, it is unlikely it
will have any impact on the viability of the cell. The other mechanism that
concerns the cell structure, is the modification of the drug target. Many bacterial
cells have the ability to modify part of the cell the drug is targeting. Methylation
and ribosomal mutations are among the most common ways for the cell to adapt
in this manner. [33]
A well-known mechanism of resistance is the bacterial cell’s ability to
modify the drug. ß-Lactamases are efficient at hydrolytic cleavage of the peptide
bond in the ß-lactam ring, which alters the drug structure. It is a common
mechanism of resistance against the ß-lactam drugs, such as penicillins and
cephalosporins. [33]
Another resistance mechanism shown in Fig. 1.11 is the action of efflux
pumps. Drug efflux is an effective and efficient form of resistance. Efflux pumps
can transcend the bacterial cell membrane and expel a variety of molecules from
the cell. Efflux pumps are often non-specific and so may expel various waste
products and unwanted foreign materials, allowing the cell to become multi-drug
resistant (MDR). [33] Efflux pumps are of potential importance in this research
effort. Further discussion of their efficacy and the importance of ion homeostasis
in bacterial cells follow in this chapter.
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1.2.2

Efflux Pumps and Ion Homeostasis. The importance of metal ions

for life on earth cannot be overemphasized. Photosynthesis, respiration, and
metabolism are all dependent on metal ions. [34] Therefore, it is no surprise that
maintaining the appropriate concentrations of metal ions within bacterial cells is
integral to cell survival. Metabolism in bacterial cells primarily depends on
adequate levels of iron, zinc and manganese ions. Without adequate levels of
specific metal ions, the cells cannot survive. Similarly, an overabundance of
metal ions is toxic to the cell. As a result, bacteria have developed complex
systems to regulate ions within the cell, maintaining ion homeostasis.
Metalloregulator enzymes, ion specific reservoirs, influx and efflux pumps, and
the cell membrane, are all essential components of ion homeostasis and cell
survival. [35]
The roles of both influx and efflux pumps are critical to survival for many cells,
with efflux pumps often being developed as a form of antibiotic resistance. As the
name suggests, influx pumps transport essential ions into the cell and therefore
can increase the concentration of essential ions inside the cell when levels are
depleted. This is a core component of the metalloregulatory process. [35]
The efflux pumps play a more significant role in terms of antibiotic resistance.
There are five families of efflux pump with most bacteria possessing more than
one type of pump. These five families have been categorized based upon their
energy source and structure. Most of the pumps transport substrates across the
cell membrane only, however, one family is capable of transporting substrates
across the entire cell envelope (cell membrane and outer membrane). A
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schematic representation of the five families of efflux pumps can be seen in Fig.
1.12. [33]

Figure 1.12 Schematic representation of the five families of
efflux pumps found in cell membranes, reproduced from AIMS
Microbiology. [33]

All of the efflux pump types are dependent upon a regulated ion gradient
for energy, with the exception of the ABC family. The ATP binding cassette
(ABC) efflux pumps use the hydrolysis of ATP to ADP as their energy source.
[33] Of course, the ATP – ADP cycle relies on proton transport in the bacterial
cell [36] so each of these efflux pumps can be affected by disruption of ion
homeostasis in the cell.
The major facilitator superfamily (MFS), small multidrug resistance (SMR)
family, multidrug and toxic compound extrusion (MATE) family, along with the
ABC family are all single-component pumps. The resistance-nodulation division
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(RND) family are multi-component pumps and comprise the one family of pumps
which are able to span the entire bacterial cell envelope. The RND efflux pumps
are found almost exclusively in Gram-negative bacteria. [33]
It is important to note that the ABC efflux pumps have very specific
substrates and are rarely found in any clinically significant bacteria. The SMR,
MFS and RND efflux pumps are much more effective at extruding antibiotic
drugs. They are all capable of removing fluoroquinolones, macrolides,
aminoglycosides, tetracyclines, and ß-lactam antibiotics, all five classes of
antibiotics. Around 50% of the efflux pumps found in E. coli are MFS pumps and
they are the most diverse pumps, in terms of substrate specificity. [33] It is
unsurprising that multi-drug resistance (MDR) is becoming more prevalent
among bacteria with efflux pumps active against all classes of antibiotics. The
emergence of methicillin-resistant Staphylococcus aureus (MRSA) and the
devastation it has caused, especially in hospital settings, is one example of this.
[23]
It is evident that the development of efflux pumps has provided bacteria an
efficient form of antibiotic resistance. By extruding the drug molecules before
they have an opportunity to work in the cell, the bacterial cells can avoid any
toxic effects. This may allow the bacterial cells time to develop other forms of
resistance to the drug molecule, therefore adding to the antibiotic resistance
problem currently facing humanity. [37] Furthermore, the number of different
efflux pumps and the diversity of their substrates, makes targeting individual
efflux pumps a particularly difficult and costly task. The common essential
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component across all families of efflux pump for effective extrusion of substrates
is an ion gradient. Disruption of ion homeostasis in the cell can remove the
energy source(s) required for efflux pump action and hold potential for
overcoming antibiotic resistance. To date, no efflux pump inhibitor has reached
the market to be co-administered with antibiotics in the treatment of bacterial
infections. Pharmacokinetic issues along with toxicity are among the issues that
have hindered promising compounds so far. The design and development of new
compounds in this area are critical and urgently needed. [37]
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1.3 Synthetic Amphiphiles for Overcoming Antimicrobial Resistance
1.3.1

Successes of Amphiphiles as Antimicrobials. Antimicrobial peptides

(AMPs), mentioned earlier in section 1.1, are short chain peptides that form part
of the immune system in multicellular organisms. [11] AMPs are often comprised
of two hydrophilic or charged residues connected, but separated and connected
by a hydrophobic region. It is this amphipathic nature of the molecules to which
their antimicrobial capabilities are attributed. [38] There are close to 1000
different AMPs identified so far. They are commonly divided into four families: (i)
anionic peptides, (ii) helical cationic peptides, (iii) anionic / cationic peptides
forming disulfide binds, and (iv) cationic peptides enriched in a specific amino
acid (such as proline, arginine, phenylalanine, glycine, or tryptophan). Their size
along with other factors, such as amphiphilicity and amino acid composition,
allow AMPs to be attracted towards and insert into the negatively charged
bacterial bilayer membranes and form pores. The “barrel-stave”, “toroidal pore”
and “carpet” models are the mechanisms by which AMPs are predicted to work
as antimicrobials. Considerable biochemical and biophysical work is currently
focused on the mechanisms of efflux pump function. [39]
One particularly interesting AMP is indolicidin, a tridecapeptide amide and a
cationic peptide (Fig. 1.13). The peptide contains only 13 amino acid residues:
H-Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH2. The high proportion
of tryptophan and proline residues makes this peptide indole-rich, hence the
inspiration for the name upon discovery. The presence of five tryptophan
residues is extremely rare for such a short peptide, in fact, this peptide had the
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highest mole percentage of tryptophan residues upon its discovery at the end of
the last century. The short chain length, and consequently small overall size and
atomic mass (1906 g/mol), were not the only surprising attributes upon isolation
of this peptide. It was found that concentrations of 10 µg/mL (10 mg/L) were
sufficient to kill suspensions of S. aureus and E. coli, thus showing efficacy
against both Gram-positive and Gram-negative bacteria. [40]

Figure 1.13 Structure of indolicidin

The use of AMPs to treat bacterial infections in clinical practice has been
employed for a considerable amount of time. Colistin, (Fig 1.14), which appears
on the World Health Organization’s (WHO) list of essential medicines, [41] was
approved for medical use in 1970. Due to toxicity concerns, the use of colistin
was very limited until the 2000’s when the prevalence of MDR bacteria surged.
[42] [43] In addition to the toxicity issues with colistin and despite the success at
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treating MDR infections, bacterial resistance has recently been observed against
colistin. [44] It is expected that any antibiotic molecule may only have a window
of 10-15 years from when it is first used to treat bacterial infections, before
resistance is developed. It is perhaps surprising that resistance to the colistin
amphiphile molecule was not observed until recently. The success of colistin,
along with other amphiphiles, such as daptomycin [23] and polymyxin B, [43]
invokes hope that other amphiphilic molecules can be designed, developed, and
utilized in the fight against antimicrobial resistance.

Figure 1.14 Structure of colistin

Some of the successes of the Gokel lab in designing and developing
amphiphiles with antimicrobial activity, have already been highlighted in this
chapter. The hydraphiles, lariat ethers, and bis(tryptophan)s have all shown
antimicrobial activity against an array of organisms including yeast and bacteria.
The antibiotic resistance of bacteria is a huge concern and so forms the main
focus of much of the Gokel lab research. Minimum inhibitory concentrations
(MICs) of various hydraphiles, lariat ethers and BTs against the K12 strain of E.
coli have been established. [26] [45] [46] While activity can vary considerably
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from one molecule to the next, MICs were established in the micromolar range
for all three families of amphiphiles.

1.3.2

Successes of Amphiphiles as Adjuvants. The use of adjuvants in

the fight against antibiotic resistance is an established plan of attack. Augmentin
is a well-established and highly successful drug cocktail, comprising amoxicillin
and clavulanate potassium as the active ingredients. The clavulanate potassium
inactivates ß-lactamases, which would otherwise provide resistance to penicillin
antibiotics, such as amoxicillin. Interestingly, many of the Gokel group
amphiphiles show adjuvant activity, in addition to being antibiotic compounds in
their own right. In recent work involving the hydraphiles, the Gokel group
investigated the mechanism of antimicrobial action of these amphiphiles. [46] It
was discovered that administration of particular hydraphiles, even at
concentrations lower than ½ MIC, along with administration of known
antimicrobials, could increase potency of these drugs by up to 30-fold against E.
coli and P. aeruginosa. In previous work, the Gokel group explained that
hydraphiles not only insert into membranes and form channels, but they also
exhibit open-close behavior (monitored using the planar bilayer lipid membrane
voltage clamp apparatus). Furthermore, a preference for cations was observed
over anions and transport of Na+ ions was preferred to K+ ions, by a ratio of 4:1.
[47] It is expected that the disruption of ion homeostasis is the foundation of the
antimicrobial activity seen, including adjuvant activity. It is logical that disruption
of a cell membrane may increase permeability of other antibiotic compounds and
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the disabling of efflux pumps will add to the accumulation of those drug
molecules inside the bacterial cells. This will, of course, lead to increased toxicity
to the cell.
Similarly, there has been interesting work into the efficacy of lariat ethers as
adjuvants, by the Gokel group. The dialkyl lariat ethers are proposed to work in a
fashion similar to hydraphiles, disrupting the cell membrane and therefore
disrupting ion homeostasis, along with the integrity of the membrane. Ion balance
is essential for many cell functions, including enzymatic functions and efflux
pumps. The Gokel lab has conducted a plethora of combination studies involving
lariat ethers and antibiotic drugs already on the market. Some of the exciting
results showing the potential of lariat ethers can be seen in Table 1.3. [45]

Table 1.3 The Effect of Lariat Ethers on the Fold Recovery of Tetracycline
Potency against the Tetracycline Resistant Strain TetR E. coli [45]
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In the first column, the lariat ether being investigated is listed. The second
column shows the MIC of the lariat ether as a drug per se against tetR E. coli, the
third column shows the concentration of the lariat ether being used. The fourth
column in the table shows the concentration of tetracycline being used (the MIC
of tetracycline against tetR is 900 µM). In the column on the right-hand side, the
fold enhancement is listed. Of the compounds listed in this study, the greatest
fold enhancement can be seen when 9 µM C10LE is used with 56 µM
tetracycline. A 16-fold enhancement was observed meaning 1/16th of the MIC of
tetracycline (when used without an adjuvant) is needed to stop growth of the
bacterial strain. [45] These data also shows that changing the chain length has
an impact on the bacterial activity of these compounds. It is unsurprising that
changes in the chain length of the lariat ethers, or indeed any amphiphile would
have an impact on their activity. In the case of these lariat ethers, increasing the
chain length not only leads to an increase in the size of the molecule, but also
causes an increase in hydrophobicity. It is understood that these lariat ethers,
like other amphiphiles, are active due to their ability to insert into cell
membranes. Cell membranes have polar and non-polar regions and so the
polar/non-polar character of amphiphiles would presumably have an impact on
their efficacy as membrane disruptors. The impact of changing chain lengths is
more complex than these two factors alone and so it is impossible to predict
exactly how changing chain length will influence antibacterial activity.
The bis(tryptophan) amphiphiles (BTs) are a third class of amphiphiles
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that have shown antibacterial activity both when used alone or as adjuvants with
other clinical antibiotics. In 2016, the Gokel lab highlighted some of the adjuvant
activity displayed by the BTs. [26] They discovered that compounds containing
arene or aliphatic linkers both showed adjuvant activity. Table 1.4 shows the
impact of co-administration of BTs to recover the potency of tetracycline against
tetR E. coli. [26]
Table 1.4 Impact of BTs on the Fold Recovery of Tetracycline
Potency against TetR E. coli [26]
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The BTs in Table 1.4 are all being used at ½ MIC or lower (second
column). It was shown that the cytotoxicity of each of these compounds to
mammalian cells was minimal at the MIC at which it was administered.
Therefore, by using concentrations at ½ MIC or lower, there would be little or no
cytotoxicity to mammalian cells. [26] The third column of the table shows the MIC
of tetracycline against the tetracycline resistant E. coli strain when the specified
concentration of amphiphile had been co-administered. The fourth column shows
the calculated fold-recovery by using the amphiphile with tetracycline. The
column on the right shows the fractional inhibitory concentration (FIC). This index
is calculated by dividing the MIC of each compound when used in combination by
the MIC of the compound when used alone. The FIC index was developed
around the Loewe additivity zero-interaction theory. This is based on the
hypothesis that a drug molecule cannot interact with itself and so a self-drug
combination will always be additive. As such, an FIC index of 1 is considered
additive, lower than 1 implies synergy and a value higher than 1 suggests
antagonism. [48] [49] Based on this understanding of the FIC index, it can be
said that all of the BTs have synergy with tetracycline against tetR E. coli. [26]
The compound that showed the greatest enhancement in potency was the
meta-Ph (L-Trp), with a 16-fold enhancement at ½ MIC. Of the aliphatic BTs, the
shortest compound, C3BT, showed the greatest fold enhancement of 8-fold.
Interestingly, when the C3BT was co-administered at ½ MIC or ¼ MIC, the fold
enhancement for the tetracycline was the same. It was noted earlier in this
chapter and in Table 1.2, that the C12BT was the most potent against tetR E. coli,
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among the BTs, even more so than meta-Ph (L-Trp). [23] It is therefore surprising
that the adjuvant activity does not follow the same trend. It can only be concluded
at this time that more investigation would be necessary before any trends can be
noted or successfully predicted.

1.3.3

The Potential for Amphiphiles for the Future. While amphiphiles

were first used clinically for their antimicrobial properties more than half a century
ago, exploration of their potential and approval for use in clinical settings both
seem to be in their infant stages. Amphiphiles may indeed prove effective as
antibiotic drugs in their own right, achieving FDA approval for new drug
molecules is an expensive and rigorous process. [50] Gaining approval for a
novel amphiphile as an adjuvant to be delivered with an existing antibiotic drug
already on the market, may be a more efficient pathway. Adjuvants are exploited
constantly in medicine, whether it is the addition of aluminum to help with
vaccines such as Infanrix (administered to children for prevention of diphtheria,
tetanus and pertussis) [51] or the use of clavulanate potassium in Augmentin.®
All three families of amphiphiles from the Gokel lab discussed in this chapter,
have shown activity as adjuvants and activity as drug molecules without being
co-administered. [23] [45] [46]
With the constant emergence of additional antibiotic resistance, it seems that
any of the classes of bacteria could be the right target. Multidrug resistance is the
most worrying and urgent threat from bacteria. Gram-positive, Gram-negative
and other bacterial types outside these classes, such as Mycobacterium
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tuberculosis are all displaying multidrug resistance. [27] The Gokel lab
compounds have significant potential to be effective against Gram-positive,
Gram-negative and MDR bacterial strains. This thesis describes additional work
to validate and expend the previous findings.
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Chapter 2
Design, Synthesis and Characterization of Bis(Tryptophan)
Amphiphiles
1.2

Introduction
There are hundreds of naturally occurring amino acids, however, the 21

common amino acids make all the proteins found in the human body and most
other forms of life. An amino acid contains an amino group (-NH2) and a
carboxylic acid group (-COOH). The common amino acids are all α-amino acids
(Aaa) meaning the α-carbon connects both the amino and carboxylic acids
groups. Furthermore, all 21 common amino acids are the L-isomer of the
molecule. The general structure of these amino acids can be seen in Fig. 2.1. [1]

Figure 2.1 General structure of amino acids [1]

The R-group varies for each of the amino acids. Side chains can be
aliphatic, aromatic, polar-neutral, amide containing, sulfur-containing, basic or
acidic. As such, the physiochemical properties of amino acids can be quite
diverse. Hydrophilicity and hydrophobicity, pKa, charges, flexibility and steric
effects of the molecules will vary depending on the R-group attached. In some
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cases, this leads to special properties, such as cysteine’s ability to form disulfide
bonds with other cysteine residues. [2]
With such variety present among the AAAs, they are most often
categorized based on whether the side chain is acidic, basic, polar, or
hydrophobic, Fig. 2.2. There is also a fifth group, “other important amino acids
with special cases” which includes amino acids such as cysteine, mentioned
previously and selenocysteine which is an analogue of cysteine containing
selenium instead of sulfur. This group also encompasses glycine, which is a
special case due to its lack of chirality of the central carbon and is more flexible
than other AAAs. Proline is also a special case as the α-carbon is part of a
pyrrolidine ring, which leads to the inclusion of a heterocycle into the polypeptide
backbone when it forms part of a polypeptide chain. [2] [3]

Figure 2.2 Diagram categorizing the 21 common amino acids
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The most interesting characteristic of the amino acid side chains for the
purposes of this research is hydrophobicity. The focus of this research is to
explore membrane-active amphiphiles for a potential antimicrobial effect. It is
known that cell membranes, including bacterial cell membranes, are comprised
of a bilayer of lipids. The phospholipids of the membrane have a hydrophilic and
a hydrophobic regime. [4] Antimicrobial peptides (AMPs) such as colistin (Fig.
2.3) [5], work by inserting into the cell membrane, disrupting ion homeostasis,
and ultimately preventing essential metabolic processes from continuing. The
structure of colistin has three clearly defined regions, including a hydrophobic tail
and hydrophilic head. Amphiphilicity is an important characteristic of AMPs,
therefore the hydrophobicity of any amino acids used in the development of
antimicrobial molecules is a primary consideration. [56] [7]

Figure 2.3 Structure of colistin. The molecule is comprised of three
main segments. Hydrophobic tail (red circle), Hydrophilic heptapeptide
ring (blue square) and a tripeptide linear region in the middle. [5]
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Another consideration is the charges of the residues. The overall surface
charge of a cell membrane can vary considerably from cell to cell. While bacterial
cells generally have a negatively charged cell wall, owing to the excess of ionized
phosphate and carboxyl groups, [8] the overall charge of a cell membrane is
influenced by the presence of charged proteins embedded in the membrane. [9]
It is often found that the inner layer of the membrane is more negatively charged
than the outer layer, which can also be problematic when trying to develop
membrane-active molecules based upon charges. [10] Furthermore, many
mammalian cells are negatively charged. Mitochondrial membranes can contain
up to 20% cardiolipin, which each have two negative charges. [11] With the
unpredictability of which cells are truly being targeted on the basis of charges,
designing membrane-active compounds based around the charges of the amino
acids, may be a futile methodology.
Tryptophan is the least abundant of the common 21 amino acids, but is found
frequently in membrane proteins. Tryptophan is most commonly observed at the
lipid-water interface and is commonly thought to play a role as a membrane
anchor. [12] Tryptophan has polar and non-polar regions and has more
hydrophobic character, due to the indole moiety, than many of the other amino
acids. All these factors make tryptophan an interesting choice when designing
antimicrobial amphiphiles.
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2.2

Rational Design
2.2.1

The Design Criteria. One of the most successful methods for

targeting bacteria is to target their cell walls and membranes. [13] As
antibacterial resistance has increased against current antibiotics, including the
efficacy of efflux pumps, [14] novel methods of targeting the bacteria cell
membranes are needed urgently. [15] Natural antimicrobial peptides (AMPs) in
nature have shown us how effective amphiphilic molecules can be as part of the
immune system. [56] [16]
Earlier work in the Gokel lab also demonstrated how effective synthetic
amphiphiles could be with the design, synthesis, and applications of hydraphiles
[17] and lariat ethers. [18] Both of these classes of compounds involved
hydrophobic cyclic systems attached to alkyl or aryl side arms or linkers. The
hydraphiles and lariat ethers have both shown antibiotic activity in the µM
concentration range. [19] [20] The success of both of these classes of
compounds heightened interest in the development of a third class of
amphiphiles, the bis(amino acid)s.

2.2.2

Successes of Bis(amino acid) Amphiphiles. In continued work into

amphiphiles, the Gokel group developed a series of bis(amino acid)s that had
varying antimicrobial potencies. While the aliphatically-linked C12BT molecule
(tryptophan residues linked by an aliphatic carbon chain containing 12 carbon
atoms) was most potent against a strain of S. aureus and a tetracycline-resistant
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strain of E. coli (tetR E. coli), it was the only active compound with an aliphatic
linker. The general structure of the bis(tryptophan)s (BTs) is shown in Fig 2.4.

Figure 2.4 General Structure of bis(tryptophan) amphiphile

The ortho-, meta- and para-phenylene BTs showed more consistent activity
than the aliphatically linked BTs. Therefore, phenylene linked bis(amino acid)
compounds were synthesized for the remaining 19 common amino acids
(selenocysteine was not included). [21] [22]
The published results from this work, including Table 1.2, show that none of
the bis(amino acid) compounds were active against Gram-positive or Gramnegative bacterial strains other than the BTs. [22] The Gokel group also
synthesized the other bis(amino acid) derivatives that have not yet been
published, none of these displayed antimicrobial activity either. This research
suggested that attention should be directed towards the BTs.
The Gokel group discovered multiple BTs were active against Gram-negative
and Gram-positive bacteria, including a strain of E. coli resistant to tetracycline,
due to the presence of the tet (A) efflux pump (tetR E. coli). The phenylene-linked
BTs all showed some level of potency, with the meta-phenylene BT being the
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most active of the three. The aliphatic-linked BTs were all essentially inactive,
with the exception of C12BT, which proved to be more potent against the E. coli
(K-12), E. coli (tetR) and S. aureus than any of the phenylene-linked compounds.
[21]
The BTs were also investigated for their cytotoxic effects. It was found that at
the MIC against tetR E. coli, the phenylene-linked BTs and the C12BT showed
minimal cytotoxic effects against various mammalian cells. [21] Furthermore, the
BTs were investigated for their adjuvant capabilities. It was found that when coadministered with tetracycline, the BTs were able to reverse antibiotic resistance
up to 16-fold against the tetR E. coli at when co-administered at sub-MIC levels.
[21]
Limited work has been carried out to investigate the mechanism(s) of action
of BTs. Ion transport studies using propidium iodide have confirmed increased
membrane permeability of S. aureus upon treatment with m-phenylene BT.
Bilayer lipid membrane (BLM) studies have indicated potential channel activity or
aggregation of the amphiphile in the membrane, although these results only
pertain to the m-phenylene BT molecule also. [22]
The results of all of the research into the three categories of amphiphiles in
the Gokel lab, in particular the efficacy of the BT molecules, has been used to
guide the direction of this research. The library of BT amphiphiles have been
expanded and additional techniques, such as ion transport studies, scanning
electron microscopy (SEM) and dynamic light scattering (DLS), were used to
better understand the mechanism(s) of action of these amphiphiles.
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2.2.3

The Library of Bis(tryptophan)s. The greatest potential yet to be

discovered was thought to be within the aliphatic-linked BTs. The C12BT showed
the highest potency so far, however, there were gaps in a potential sequence of
compounds. C3BT, C4BT and C6BT were the other three aliphatic BTs that had
been synthesized and their activities investigated, however, none were
biologically active. [21] [22] The thickness of the insulator regime of the
phospholipid membrane is estimated to be in the 30-35 Å range so it would seem
logical that longer chain molecules might transverse the membrane and
potentially be more active. This would however require a carbon chain of 20
carbons in length, or greater, and there may be solubility issues with such a
molecule. Furthermore, the mechanism of action seems not to require the
molecule to span the entire thickness of a membrane, based on the activity of the
C12BT and phenylene-linked BT molecules. The latter certainly would be much
shorter. It would therefore be proposed that the “gaps” in the series of aliphatic
BTs be addressed first and exploration to continue from that point.
The new compounds that were synthesized for the purposes of this research
are C8BT, C10BT and C14BT. Extra quantities of the other BTs were also
synthesized as required for analytical and biological experimentation. The entire
library of compounds being investigated, and their structures are shown in Fig.
2.5. All compounds were synthesized as HCl salts and using the L-isomer of
tryptophan (e.g. (CH2)12(L-Trp)2∙2HCl = C12BT).
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C3BT
(CH2)3(L-Trp)2∙2HCl

C4BT
(CH2)4(L-Trp)2∙2HCl

C10BT*
(CH2)10(L-Trp)2∙2HCl

C8BT*
(CH2)8(L-Trp)2∙2HCl

C12BT
(CH2)12(L-Trp)2∙2HCl

o-PhBT
ortho-C6H4(L-Trp)2∙2HCl

C6BT
(CH2)6(L-Trp)2∙2HCl

C14BT*
(CH2)14(L-Trp)2∙2HCl

m-PhBT
meta-C6H4(L-Trp)2∙2HCl

p-PhBT
para-C6H4(L-Trp)2∙2HCl

Figure 2.5 Names and structures of the BTs investigated. The compounds that
were first prepared as part of this research are marked with an asterisk (*)
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2.3

Synthesis
The general procedure for the synthesis of BTs was available in the

literature, [21] however some specific details were lacking. Thus considerable
“trial and error” was required. Initially, it was assumed that the linker should be
added at the beginning of the reaction at the same time as the tryptophan. As it
turned out, this sequence failed to yield pure white solid product. The crude
material would contain a little starting material, but mostly “contaminants.” The
NMR spectra were complex at this time. Eventually, it was decided that the
tryptophan, DMF, HBTU and diisopropylethylamine may need to react for some
time before the diamine could be coupled. The decision was also taken to try to
isolate the crude product before attempting the deprotection and productisolation steps. This led to the first breakthrough; the synthesis of a crude product
that resembled the description in the literature. The NMR spectrum and melting
point confirmed synthesis of the first BOC-protected BT of this research.
The isolated crude m-PhBT was dissolved in an appropriate solvent and
then deprotected using HCl in dioxane. Choosing a suitable solvent was
problematic. Methanol, the solvent suggested in the literature failed to afford
product. Dioxane was eventually chosen and the deprotection was left overnight.
In an attempt to ensure the reaction would have sufficient time, 24 hours was
allowed for this step, initially. The crude product was a dark red/brown viscous
liquid. The NMR showed remnants of the crude product; it was possible that HCl
was degrading the compound.
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Through trial and error, an inert environment was identified for the
deprotection step, and a shorter reaction time of 16 hours was found to be
sufficient. Thus, a yellow liquid resulted. Upon addition of cold hexane, a solid
could be extracted. Trituration with cold DCM afforded the desired white solid /
powder.
As the research progressed, it was discovered that the deprotection step
could be achieved in high yield in less than an hour. It was also found that the
overnight time frame for the initial coupling could be achieved in less than 3
hours with equivalent yields. The most time-consuming step was purification of
the final product: a significant number of washes were required to achieve a pure
product. The reaction scheme for the synthesis of m-PhBT [meta-C6H4(LTrp)2∙2HCl] is shown in Fig. 2.6.

Figure 2.6 Synthetic scheme for m-PhBT (R = CH2-Indole).
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When an appropriate sequence was established, this synthetic pathway
was chosen to form part of an advanced organic course for undergraduate
students at the University of Missouri – St. Louis. The students would be tasked
with developing a synthesis for the specified product (m-PhBT). The BOCprotected tryptophan and the meta-phenylenediamine were specified as starting
reagents. The students were guided along the way with respect to solvent
choices, purification techniques and the use of an inert environment. All of the
students in the class were able to successfully synthesize the desired product.
Purity and yields, of course, significantly varied, but the student feedback about
how much they learned was very positive.
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2.4

Analysis and Characterization

2.4.1

Physical Characteristics. The yields and physical characteristics of

each of the compounds prepared is given in Table 2.1.
Table 2.1 Physical Characteristics of BTs. Data for non-novel compounds taken from
literature [21]

Compound

Appearance

Yield (%)

Melting Point (°C)

C3BT

White Powder

57

234

C4BT

White Powder

89

204

C6BT

White Powder

61

193

C8BT

White Powder

70

182

C10BT

White Powder

68

171

C12BT

White Powder

93

158

C14BT

Off-White Solid

61

156

o-PhBT

White Powder

34

201

m-PhBT

White Powder

80

223

p-PhBT

White Powder

83

237

The BTs were obtained as white powders, with the exception of the largest
molecule, C14BT. The longer alkyl chain made this compound more difficult to
synthesize and to handle generally. The compound, after many washes
remained a light-brown viscous oil. Upon drying a solid was formed, but the same
white color could not be achieved.
The yields varied considerably from compound to compound. A low of
34% yield was observed for the o-PhBT. This is somewhat surprising as the
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para-substituted BT had a high yield of 83%, similar to the 80% yield observed by
the m-PhBT. In organic synthesis, activating groups tend to favor the ortho and
para-substitution, while deactivating groups are meta-directing. Based on these
electronic effects, it would be expected that the ortho- and para-substituted BTs
would have similar yields. It may be that steric factors were blocking the effective
coupling to both positions of the phenyl ring and that is why there is such a drop
in the yield for the o-PhBT.
The melting points are listed in the final column of Table 2.1. For the
aliphatic BTs, there is an obvious trend: as the chain lengths increase, the
melting points decrease. A common trend exists for families of simple,
unbranched, aliphatic, organic molecules: as the chain length of the molecule
increases, the melting point increases. This is often explained by the fact longer
chains will allow for more van der Waal’s forces to be exerted. There are of
course many other impacts to consider including hydrogen bonding, flexibility,
and eccentricity and shape of the molecules. [23] Predicting the melting point of
any new family of compounds may be considered a fool’s errand. While many
families of compounds follow the trend of increasing melting points with
increased chain lengths, such as halogenated alkanes, alkanols, alkylamines and
alkanoic amides, [23] there are also many that do not. Ionic liquids, for example,
show an interesting trend in melting points. The ionic liquids with “short” alkyl
chains, follow a trend of decreasing melting points as alkyl chain lengths
increase. Ionic liquids that have “long” alkyl chains follow a trend of increasing
melting points as the alkyl chain increases. [24] For these reasons, it is a
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pleasant discovery that melting points of the aliphatic BTs in Table 2.1 are
inversely proportional to the chain lengths of the molecules.
The three phenylene-linked BTs also display a trend with regard to their
melting points. In this case, the melting points seem to relate to the steric strain
of the molecule. The less sterically restricted the molecule is, the more stable it
appears to be and so a higher melting point is observed. Of course, there are
many other factors involved, as previously mentioned, but the extent to which
those are involved has not been estimated or quantitated.

2.4.2

Nuclear Magnetic Resonance (NMR) Data. All the 1H-NMR spectra

were determined at 300 MHz in CD3OD. The spectrum for C14BT, Fig. 2.7,
shows the proton peaks expected for the compound, solvent peaks, and a
reference peak (TMS) at 0.0 ppm, are present. For reference, the solvent peaks
are: ẟ 3.304 (methanol), 3.653 (dioxane), 4.911 (H2O), 5.491 (dichloromethane).
C14BT proton peaks: ẟ 1.11-1.42 ppm (m, 24H, aliphatic CH2), 2.96-3.40 ppm (m,
8H, -CH2CH2NH-, CH2ß), 4.02 ppm (ABX, 2H, CHα), 7.02-7.15 ppm (m, 4H,
indole H5, indole H6) 7.18 ppm (s, 2H, indole H2), 7.36 ppm (d, 2H, indole H7),
7.60 ppm (d, 2H, indole H4).
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Figure 2.7 1H-NMR Spectrum for C14BT in CD3OD at 300 MHz

The proton peaks for each of the other BTs are given in Table 2.2. The
data for the previously reported compounds have been taken from the literature.
[21] All other 1H-NMR was obtained experimentally, first-hand.
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Table 2.2 1H-NMR peaks for all the BTs. Data for previously reported
compounds taken from the literature [21]
Compound
C3BT

1H-NMR

Peaks (ppm)

ẟ 1.40 (m, 2H, -CH2CH2NH-), 2.98 (m, 4H, -CH2CH2NH-),
3.22-3.65 (m, 4H, CH2ß) 4.13 (ABX, 2H, CHα), 6.99-7.18
(m, 4H, indole H5, indole H6) 7.25 (s, 2H, indole H2), 7.39
(d, 2H, indole H7), 7.69 (d, 2H, indole H4).

C4BT

ẟ 1.18 (m, 2H, -CH2CH2NH-), 3.05 (m, 4H, -CH2CH2NH-),
3.22-3.41 (ABX, 2H, CH2ß) 4.09 (ABX, 2H, CHα), 7.05-7.17
(m, 4H, indole H5, indole H6) 7.23 (s, 2H, indole H2), 7.40
(d, 2H, indole H7), 7.66 (d, 2H, indole H4).

C6BT

ẟ 1.05 (m, 2H, aliphatic CH2),1.26 (m, 2H, aliphatic CH2),
2.97-3.39 (m, 4H, -CH2CH2NH-, CH2ß), 4.06 (ABX, 2H,
CHα), 7.02-7.15 (m, 4H, indole H5, indole H6) 7.20 (s, 2H,
indole H2), 7.37 (d, 2H, indole H7), 7.63 (d, 2H, indole H4).

C8BT

ẟ 1.02-1.38 (m, 12H, aliphatic CH2), 2.97-3.42 (m, 8H, CH2CH2NH-, CH2ß), 4.04 (ABX, 2H, CHα), 7.02-7.16 (m,
4H, indole H5, indole H6) 7.20 (s, 2H, indole H2), 7.36 (d,
2H, indole H7), 7.64 (d, 2H, indole H4).

C10BT

ẟ 1.01-1.38 (m, 16H, aliphatic CH2), 2.92-3.35 (m, 8H, CH2CH2NH-, CH2ß), 3.99 (ABX, 2H, CHα), 7.00-7.14 (m,
4H, indole H5, indole H6) 7.15 (s, 2H, indole H2), 7.31 (d,
2H, indole H7), 7.59 (d, 2H, indole H4).

C12BT

ẟ 1.08-1.34 (m, 20H, aliphatic CH2), 2.96-3.40 (m, 8H, -
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CH2CH2NH-, CH2ß), 4.04 (ABX, 2H, CHα), 7.02-7.15 (m,
4H, indole H5, indole H6) 7.20 (s, 2H, indole H2), 7.37 (d,
2H, indole H7), 7.62 (d, 2H, indole H4).
C14BT

ẟ 1.11-1.42 (m, 24H, aliphatic CH2), 2.96-3.40 (m, 8H, CH2CH2NH-, CH2ß), 4.02 (ABX, 2H, CHα), 7.02-7.15 (m,
4H, indole H5, indole H6) 7.18 (s, 2H, indole H2), 7.36 (d,
2H, indole H7), 7.60 (d, 2H, indole H4).

o-PhBT

ẟ 3.35-3.65 (ABX, 2H, ßCH2), 4.58 (t, 1H, αCH), 7.00-7.73
(m, 7H, ArH, ArNH)

m-PhBT

ẟ 3.33-3.53 (ABX, 4H, 2CH2ß), 4.26 (ABX, 2H, 2CHα), 7.01
(t, 2H, indole H5), 7.12 (t, 2H, indole H6) 7.22 (s, 2H, indole
H2), 7.26 (m, 2H, phenylene H4), 7.27 (m, 1H, phenylene
H5), 7.38 (d, 2H, indole H7), 7.67 (d, 2H, indole H4)., 7.93
(s, 2H, phenylene H2).

p-PhBT

ẟ 3.34-3.54 (ABX, 2H, CH2ß), 4.27 (ABX, 1H, CHα), 6.977.14 (m, 2H, indole H5, indole H6), 7.24 (s, 1H, indole H7)
7.38 (d, 1H, indole H7), 7.67 (d, 1H, indole H4).
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2.4.3

Electrospray Ionization (ESI) Mass Spectroscopy Data. Mass

spectrometry data were obtained at the UMSL chemistry department facilities.
Liquid chromatography and mass spectrometry are used so the purity of the
product can be verified at this stage. Fig. 2.8 shows the chromatograph and
mass spectrum for C14BT.

Figure 2.8 Chromatograph and mass spectrum of C14BT dissolved in
methanol.
The top panel of Fig. 2.8 shows the chromatograph. It shows that the C14BT
sample is virtually pure given that only one major peak is detected during the
liquid chromatography. The lower panel shows the mass spectrometry data. It
shows the major ion peaks for C14BT, which exists as (CH2)14(L-Trp)2∙2HCl, the
hydrochloride salt. The mass to charge ratio (m/z) of the base peak is observed
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as 301.2161 (C14BT2+) while the second most abundant peak is 601.4249
(C14BT+). This represents the single and double charged species, which both
exist in the sample. The mass spectrum confirms the identity of the C14BT, which
has a calculated mass of 601.4152 g/mol. Below the graphs, the error has been
calculated. The error for each is within 5 ppm, well within the accepted margin of
error. Mass spectrometry data, such as that shown in Fig. 2.8, was collected for
all the BTs. The data from each of these has been summarized in Table 2.3.

Table 2.3 Mass Spectroscopy data for BTs. Data for non-novel compounds
taken from the literature [21]
Compound

Calculated Mass

Experimental

(g/mol)

Mass (g/mol)

C3BT

447.2503

447.2503

0

C4BT

461.2660

461.2668

-1.7

C6BT

489.2973

489.2972

+0.2

C8BT

518.3358

518.3364

-1.2

C10BT

546.3671

546.3677

-1.1

C12BT

573.3912

573.3929

-3.0

C14BT

601.4152

601.4125

+4.5

o-PhBT

481.2347

481.2359

-2.5

m-PhBT

481.2347

481.2356

-1.9

p-PhBT

481.2347

481.2346

0
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Error (ppm)

The data in Table 2.3 show that each synthesized BT compound had a mass
close to the calculated mass, with the exception of the p-PhBT (+674.3 ppm).
This compound was not synthesized as part of this work. The extremely small
margin of error for the other BTs confirmed the identification of the BTs
synthesized.

2.4.4 Crystal Formation. For decades, X-ray crystallography has been a
preferred method to obtain structural information of small molecules, proteins,
and biological macromolecules. A three-dimensional molecular structure can be
obtained following the crystallization of a pure sample of the compound or
specimen. Diffraction patterns of the X-ray beam are processed, and the
repeating sub-units of the crystal can be determined. Diffraction spots can be
used to determine structure factors which can in turn be used to create an
electron density map. Further processing and refinement of the mapping allows
for a three-dimensional molecular structure to be obtained. [25]
To date, no crystal structure has been obtained for any of the BTs included in
this research. It was decided that crystal structures could be useful to help
understand potential interactions within a membrane of the BTs and their
potential going forward. There are many different methods used for crystal
formation and growing, including slow cooling, vapor diffusion, seeding,
convection, slow evaporation, and even more specialized methods, such as cocrystallization and diffusion of reagents. [26] Slow evaporation is one of the less
complicated methods to perform. The downsides to this method are the larger
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quantities of compound needed and significant volumes of solvents are required.
A significant stock of m-PhBT was on hand and it has one of the higher melting
points among the BTs. Thus, forming crystals may be more achievable by using
this compound, compared to other BTs. The slow evaporation method is usually
only avoided when the compounds are air-sensitive or when being performed in
a dry box. It was decided that slow evaporation would be most useful in the
attempt to produce crystals of the BTs. Table 2.4 shows the solvent systems
used, the conditions and the data gained so far.
For the slow evaporation method of crystal formation, it is imperative to first
dissolve the compound in a minimal amount of solvent. The solution should be as
concentrated as possible. A co-solvent is then added, if using a solvent system.
This co-solvent should not dissolve the compound on its own and should have a
similar, or slightly lower boiling point than the original solvent. The BTs are
known to be soluble in methanol, ethanol, and water. These are the initial
solvents used in each of the systems. The vials were covered with a dust guard
and a small opening made in the lid to facilitate slow evaporation of the solvents.
Most of the systems were tried at room temperature (RT). On some occasions,
the temperature had been lowered to 5 °C to encourage slower evaporation. At
room temperature, complete evaporation of solvents happened within 14 days. At
5 °C, it took almost twice as long (25+ days), depending on the opening size and
solvent used. Crystals should form before complete evaporation.
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Table 2.4 Compounds and solvent systems attempted for crystal growing.

Table 2.4 shows the 35 combinations that have been tried to date. No useful
crystals have been obtained to date.
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2.5

Conclusion
The aim of the work recorded in this chapter was to build upon the existing

library of bis(tryptophan) amphiphiles (BTs). The library was expanded to include
C8BT, C10BT and C14BT, which had not been synthesized prior to this work.
Analytical techniques, such as LC-MS and 1H-NMR were used to confirm
successful syntheses and attempts were made to resolve the first crystal
structure for this family of compounds. A trend was observed for this group of
compounds with regards to their melting points. As the length of the aliphatic
linker, and thus the molecular weight of the molecule increased, the melting point
decreased.
The synthetic procedure was also refined. Previous synthetic procedures
were optimized to include reduced reaction times. The procedure was simplified
and was successfully used to form a multi-step synthetic project for 3000 level
undergraduate organic chemistry at UMSL.
Future work involving the synthesis of BTs might include synthesis of
amphiphiles with linkers containing an odd number of carbons in the chain, for
example, C7BT,C9BT, C11BT and so on. It is worth noting that the characteristics
may change significantly when the chain length is changed. Previous work in the
Gokel lab showed that the dialkyl-substituted lariat ethers could be solids at room
temperature when the alkyl side chains contained an even number of carbons,
[27] but a liquid when the number of carbons was an odd number. [18] It was
notable that the C10LE and C12LE both form solids at room temperature while the
C11LE is an oil. Considerations such as this should be made if planning future
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synthetic work with the BTs.
Other work might include the synthesis of longer chains beyond C14BT.
Given the solubility issues experienced with the C14BT during the synthesis, the
procedure may need amended to include less-polar solvents, if this is attempted.
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2.6

Experimental Details
All of the BTs were prepared according to the general procedure

published by the Gokel group in 2016. [21] Adjustments and modifications were
made as necessary depending on the specific properties of the reagents used
and the intricacies of product isolation.
General Procedure
Dissolve tert-butyloxycarbonyl-protected (BOC-protected) tryptophan (2.0
equivalents, 2.5 mmol) and HBTU (2.1 equivalents, 2.7 mmol) in 10 mL
anhydrous dimethylformamide (DMF). Place reaction mixture under argon and in
an ice-bath. Add diisopropylethylamine (6.0 equivalents, 1.3 mL) and stir for 30
minutes. Dissolve diamine (1.25 mmol, 1.0 equivalent) in minimal amount of DMF
and inject into amino acid mixture. Remove from ice bath and continue to stir at
room temperature overnight (12-16 hours). The mixture is taken up in 75 mL
ethyl acetate and washed with 1 M NaHSO4 (2 x 75 mL), 5% NaHCO3 (3 x 50
mL) and brine solution (2 x 75 mL). The organic layer is dried via filtration though
a plug consisting of a 50:50 mixture of MgSO4 and Celite©. The solvent is
removed in vacuo. This yields the BOC-protected product. Deprotection was
carried out using 4.0 M HCl in dioxane (10 equivalents, 3.5 mL), under argon.
The product is isolated by precipitation using cold hexanes and trituration using
cold dichloromethane. Structure and purity confirmed using 1H-NMR and LC-MS.
Melting point was determined using Fischer Scientific melting point apparatus.
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C3BT [(CH2)3(L-Trp)2∙2HCl] was prepared according to the general procedure
using 1,3-diaminopropane dihydrochloride (200 mg, 1.36 mmol). The product
was obtained as a white powder (346 mg, 57% yield), mp 234 °C. 1H-NMR
(CD3OD): ẟ 1.40 (m, 2H, -CH2CH2NH-), 2.98 (m, 4H, -CH2CH2NH-), 3.22-3.65
(m, 4H, CH2ß) 4.13 (ABX, 2H, CHα), 6.99-7.18 (m, 4H, indole H5, indole H6)
7.25 (s, 2H, indole H2), 7.39 (d, 2H, indole H7), 7.69 (d, 2H, indole H4). HRMS
(FAB+) Calcd (C25H31N6O2+): 447.2503 Found: 447.2503

C4BT [(CH2)4(L-Trp)2∙2HCl] was prepared according to the general procedure
using 1.4-diaminobutane dihydrochloride (210 mg, 1.30 mmol). The product was
obtained as a white powder (534 mg, 89% yield), mp 204 °C. 1H-NMR (CD3OD):
ẟ 1.18 (m, 2H, -CH2CH2NH-), 3.05 (m, 4H, -CH2CH2NH-), 3.22-3.41 (ABX, 2H,
CH2ß) 4.09 (ABX, 2H, CHα), 7.05-7.17 (m, 4H, indole H5, indole H6) 7.23 (s, 2H,
indole H2), 7.40 (d, 2H, indole H7), 7.66 (d, 2H, indole H4). HRMS (FAB+) Calcd
(C26H33N6O2+): 461.2660 Found: 461.2668

C6BT [(CH2)6(L-Trp)2∙2HCl] was prepared according to the general procedure
using 1,6-diaminohexane dihydrochloride (250 mg, 1.32 mmol). The product was
obtained as a white powder (394 mg, 61% yield), mp 193 °C. 1H-NMR (CD3OD):
ẟ 1.05 (m, 2H, aliphatic CH2),1.26 (m, 2H, aliphatic CH2), 2.97-3.39 (m, 4H, CH2CH2NH-, CH2ß), 4.06 (ABX, 2H, CHα), 7.02-7.15 (m, 4H, indole H5, indole
H6) 7.20 (s, 2H, indole H2), 7.37 (d, 2H, indole H7), 7.63 (d, 2H, indole H4).
HRMS (FAB+) Calcd (C28H37N6O2+): 489.2973 Found: 489.2972
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C8BT [(CH2)8(L-Trp)2∙2HCl] was prepared according to the general procedure
using 1,8-diaminooctane (180 mg, 1.25 mmol). The product was obtained as a
white powder (453 mg, 70% yield), mp 182 °C. 1H-NMR (CD3OD): ẟ 1.02-1.38
(m, 12H, aliphatic CH2), 2.97-3.42 (m, 8H, -CH2CH2NH-, CH2ß), 4.04 (ABX, 2H,
CHα), 7.02-7.16 (m, 4H, indole H5, indole H6) 7.20 (s, 2H, indole H2), 7.36 (d,
2H, indole H7), 7.64 (d, 2H, indole H4). HRMS (ESI) Calcd (C30H41N6O2+):
518.3358 Found: 518.3364

C10BT [(CH2)10(L-Trp)2∙2HCl] was prepared according to the general procedure
using 1,10-diaminodecane (215 mg, 1.25 mmol). The product was obtained as a
white powder (464 mg, 68% yield), mp 171 °C. 1H-NMR (CD3OD): ẟ 1.01-1.38
(m, 16H, aliphatic CH2), 2.92-3.35 (m, 8H, -CH2CH2NH-, CH2ß), 3.99 (ABX, 2H,
CHα), 7.00-7.14 (m, 4H, indole H5, indole H6) 7.15 (s, 2H, indole H2), 7.31 (d,
2H, indole H7), 7.59 (d, 2H, indole H4). HRMS (ESI) Calcd (C32H45N6O2+):
546.3671 Found: 546.3677

C12BT [(CH2)12(L-Trp)2∙2HCl] was prepared according to the general procedure
using 1,12-diaminododecane (250 mg, 1.25 mmol). The product was obtained as
a white powder (667 mg, 93% yield), mp 158 °C. 1H-NMR (CD3OD): ẟ 1.08-1.34
(m, 20H, aliphatic CH2), 2.96-3.40 (m, 8H, -CH2CH2NH-, CH2ß), 4.04 (ABX, 2H,
CHα), 7.02-7.15 (m, 4H, indole H5, indole H6) 7.20 (s, 2H, indole H2), 7.37 (d,
2H, indole H7), 7.62 (d, 2H, indole H4). HRMS (ESI) Calcd (C34H49N6O2+):
573.3912 Found: 573.3929
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C14BT [(CH2)14(L-Trp)2∙2HCl] was prepared according to the general procedure
using 1,14-diaminotetradecane (285 mg, 1.25 mmol) . The product was obtained
as a white powder (459 mg, 61% yield), mp 156 °C. 1H-NMR (CD3OD): ẟ 1.111.42 (m, 24H, aliphatic CH2), 2.96-3.40 (m, 8H, -CH2CH2NH-, CH2ß), 4.02 (ABX,
2H, CHα), 7.02-7.15 (m, 4H, indole H5, indole H6) 7.18 (s, 2H, indole H2), 7.36
(d, 2H, indole H7), 7.60 (d, 2H, indole H4). HRMS (ESI) Calcd (C36H53N6O2+):
601.4152 Found: 601.4125

o-PhBT [ortho-C6H4(L-Trp)2∙2HCl] was prepared according to the general
procedure using 1,2-phenylenediame (150 mg, 1.39 mmol). The product was
obtained as a white powder (227 mg, 34% yield), mp 201 °C. 1H-NMR (CD3OD):
ẟ 3.35-3.65 (ABX, 2H, ßCH2), 4.58 (t, 1H, αCH), 7.00-7.73 (m, 7H, ArH, ArNH)
HRMS (FAB+) Calcd (C28H28N6O2+): 481.2347 Found: 481.2359

m-PhBT [meta-C6H4(L-Trp)2∙2HCl] was prepared according to the general
procedure using 1,3-phenylenediame (150 mg, 1.39 mmol). The product was
obtained as a white powder (535 mg, 80% yield), mp 223 °C. 1H-NMR (CD3OD):
ẟ 3.33-3.53 (ABX, 4H, 2CH2ß), 4.26 (ABX, 2H, 2CHα), 7.01 (t, 2H, indole H5),
7.12 (t, 2H, indole H6) 7.22 (s, 2H, indole H2), 7.26 (m, 2H, phenylene H4), 7.27
(m, 1H, phenylene H5), 7.38 (d, 2H, indole H7), 7.67 (d, 2H, indole H4)., 7.93 (s,
2H, phenylene H2). HRMS (ESI) Calcd (C28H28N6O2+): 481.2347 Found:
481.2356
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p-PhBT [para-C6H4(L-Trp)2∙2HCl] was prepared according to the general
procedure using 1,4-phenylenediame (150 mg, 1.39 mmol). The product was
obtained as a white powder (555mg, 83% yield), mp 237 °C. 1H-NMR (CD3OD): ẟ
3.34-3.54 (ABX, 2H, CH2ß), 4.27 (ABX, 1H, CHα), 6.97-7.14 (m, 2H, indole H5,
indole H6), 7.24 (s, 1H, indole H7) 7.38 (d, 1H, indole H7), 7.67 (d, 1H, indole
H4). HRMS (FAB+) Calcd (C28H28N6O2+): 481.2347 Found: 481.2346
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Chapter 3
Biological Activity of Bis(Tryptophan) Amphiphiles
3.1 Introduction
An important aim of this research was to determine if the bis(tryptophan)
amphiphiles (BTs) are biologically active. While no specific microbe is the target
of this research, it would be preferred if the compounds were active against both
Gram-negative and Gram-positive bacteria. These two classes of bacteria have
significantly different cell envelope structures (Fig. 3.1). [1]

Figure 3.1. Schematic representations of the cell envelopes of Gram-negative and
Gram-positive bacteria as illustrated by Heger et al. [1]

It is known that the cell membrane provides a barrier to entry in the
bacterial cell against foreign materials, such as toxins or drugs. [2] If the BTs are
to target the cell membrane, or if they need to pass through the membrane, then
their efficacy as antibacterial agents may be altered depending on the type of cell
membrane. As seen in Fig. 3.1, the Gram-negative cell envelope has two
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membrane layers. Both of these layers may need to be penetrated or disturbed
by the BTs if they are to be bactericidal. The amphiphilic nature of the cell
membranes is part of their success as barriers into the cell. Two such
membranes make the cell more difficult to penetrate. The Gram-negative
bacteria have a relatively small number of peptidoglycans in the periplasmic
space between the inner and outer membranes. The Gram-positive bacterial
envelope is different as it lacks an outer membrane. Instead, it has a significantly
more complex peptidoglycan layer on the outside of the cytoplasmic membrane.
This peptidoglycan layer can be up to 80 nm in thickness, which can be 10 times
as thick as the peptidoglycan layer in Gram-negative bacteria. [1] Because of the
differences in cell envelope structure, the efficacy of BTs against both Gramnegative and Gram-positive bacteria were explored.
The international concern over antibiotic resistance is justified. The World
Health Organization (WHO) has designated antimicrobial resistance (AMR) as
one of the ten greatest health crises facing humanity. [3] One component of AMR
is the evolution of bacteria into strains that possess multi-drug resistance (MDR).
Therefore, in this research, the efficacy of the BTs against a multi-drug resistant
strain of bacteria will also be investigated. This will be a MDR strain of E. coli,
(BAA-3058 from American Type Culture Collection). This strain is resistant to a
range of antibiotics including aztreonam, ciprofloxacin, levofloxacin and cefepime
(Fig 3.2). It is susceptible to some AMPs such as colistin. [4]
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Figure 3.2 Structures of aztreonam, ciprofloxacin and levofloxacin

To assess the efficacy of the BTs against bacteria, minimum inhibitory
concentration (MIC) studies were conducted. These studies were conducted in
accordance with the methods described by the Clinical and Laboratory Standards
Institute. [5] The bacterium being used in the investigation was grown to a
specified optical density and added to the bis(tryptophan) that was serially diluted
by halves until the growth is inhibited by greater than 90% (MIC90), detected
spectroscopically. Each of the BTs were dissolved in DMSO, and the solvent
concentration was kept constant at 0.5% by volume in all experiments. The BTs
investigated were C3BT, C4BT, C6BT, C8BT, C10BT, C12BT and C14BT. The data
reported here included two replicates and a minimum of three trials each. All
MICs are reported in µM with a value of >128 µM meaning that no growth
inhibition was observed up to 128 µM. The MIC could be much higher, but such
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values are usually not biologically useful.
The MIC experiments were conducted in 96-well plates. Fig. 3.3 shows
how the plates are set-up. Phosphate buffered saline (PBS) solution is placed in
each of the wells on the perimeter of the plate. This helps mitigate the
evaporation which may occur when the plates are in the incubator. In the second
column from the left, media is placed in each of the wells, without any bacterial
cells. The specific media used is Mueller-Hinton broth II (MHII). It contains casein
acid hydrolysate (1.75% w/v), beef extract (0.30% w/v) and starch (0.15% w/v).
The wells in this second column act as the negative control (absence of cell
growth). The third column of wells have media and bacterial cells present and
demonstrate the growth of the bacteria without any of the BTs being present
(positive control). In the next four columns, the wells contain media, cells, and
varying concentrations of the first test compound (C8BT is used as an example).
The BT concentration range used is 128 µM to 0.125 µM. Duplicates are
produced at the same time to eliminate error. The wells in the remaining four
columns contain the second compound being investigated (C10BT). The same
plate set-up is used for all of the MIC studies in this research, with the only
differences being the bacterial cell line or BT being used. All MIC studies were
reproduced in triplicate.
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Figure 3.3 Diagram showing the plate set-up used for the MIC experiments. All
concentrations of BT being used are given in µM. The bacterial strain and
compounds being investigated will vary.
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3.2 Efficacy against Gram-negative Bacteria
The most widely used microorganism in biological research laboratories is
E. coli. The E. coli (K-12) cell line is known for its fast-growth capabilities in
inexpensive media. [6] As such, it has been used in this research as the bacterial
strain to investigate the antibacterial activity of the BTs against Gram-negative
bacteria and the first screening of the BTs for biological activity.
Table 3.1 shows the MICs of the aliphatic BTs against E. coli (K-12). The
most potent of the compounds is the compound with the longest hydrocarbon
chain, C14BT. As the length of the carbon chains decrease from C14BT to C8BT,
the MICs increase from 8 µM to 128 µM. C3BT, C4BT and C6BT are considered
virtually inactive against E. coli (K-12), for the purposes of this research because
of their MIC values are 128 µM or greater. The structures of the BTs are shown
in Fig. 3.4.
Table 3.1 Minimum Inhibitory Concentrations (MICs) against E. coli (K-12)
Compound

MIC (µM)

C3BT

>128

C4BT

>128

C6BT

>128

C8BT

128

C10BT

32-64

C12BT

8-16

C14BT

8
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Figure 3.4 Names and structures of the BTs investigated. The compounds that
were first prepared as part of this research are marked with an asterisk (*)

The apparent trend in potency for these compounds suggests that
antibacterial potency of the BTs correspond to the length of the hydrocarbon
chain. Why this might be the case is less than obvious. The estimated thickness
of the hydrocarbon portion of a bilayer membrane is approximately 35 Å, which
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would still exceed the anticipated length of even the longest of the BTs, C 14BT.
[7] The E. coli cells have two such membranes in their cell envelope, (Fig. 3.1) in
addition to a peptidoglycan layer separating the membranes. [1] It is not
reasonable for the BTs to be able to span the entire cell envelope or create a
channel or pore without some sort of secondary structure or self-assembly. In
previous work, the Gokel lab showed that some other BTs form ion-conducting
pores in bilayer membranes, which may, at least in part, be responsible for the
antimicrobial properties of the BTs. [7]
Many amphiphiles are known to aggregate, most commonly forming
micelles, but also forming various other structures. [8] Cell membranes, for
example, are an aggregation of amphiphiles. [9] Antimicrobial peptides (AMPs)
are known to disrupt ion homeostasis in microbes, including bacteria, by forming
channels or pores in the cell membrane. [10] It may be possible that the BTs are
forming pores or channels in the E. coli membranes via aggregation. This will be
discussed further later in the next chapter.
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3.3 Efficacy against Gram-positive Bacteria
After the initial screening with a Gram-negative bacterium, E. coli, a
second screening of the BTs was completed. On this occasion the Gram-positive
S. aureus was used. The specific strain (BAA-1720) is a methicillin-resistant S.
aureus (MRSA) strain.
MRSA is most commonly known as a persistent, hospital-acquired
bacterial infection, which has proven difficult to treat. [11] It was first recognized
in the 1960’s but has become a more significant concern over time. In 2014, the
WHO gave considerable attention to the global threat of MRSA, in their first
global report on antibiotic resistance. [12] It was noted that those with MRSA
were 64% more likely to die than those infected with a non-resistant strain. In
2005, there were over 90,000 invasive MRSA infections in the US alone. [13] In
the EU, more than 150,000 patients annually are affected by MRSA with an
estimated cost of almost €400M ($440M) to the healthcare systems. [14]
Undoubtedly, potency against MRSA would be an exciting attribute for our BT
compounds.
Table 3.2 shows the MICs of the aliphatic BTs against MRSA (BAA-1720).
The results show that the MICs for the C3BT, C4BT and C6BT are once again too
high for those compounds to be considered biologically relevant. The C8BT,
C10BT, C12BT and C14BT all show potency at 64 µM or lower. The activity of the
C12BT and C14BT are particularly interesting. Potency below 10 µM is of
particular interest as biological activity is more likely to be observed at
concentrations which are not toxic to mammalian cells. In previous work, the
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Gokel lab established that human embryonic kidney cells (HEK-293) and
Cercopithecus aethiops kidney cells (Cos-7) had an 80-100% survival rate when
exposed to 10 µM C12BT for 24 hours. [15]

Table 3.2 Minimum Inhibitory Concentrations (MICs) against S. aureus
Compound

MIC (µM)

C3BT

128-256

C4BT

1024

C6BT

512

C8BT

32-64

C10BT

16

C12BT

4-8

C14BT

≤4

Similar to the results against the E. coli (K-12) (Table 3.1) it is notable that
as the hydrocarbon chain length in the BT increases, the MIC against the
bacterial strain decreases and potency increases. This suggests a correlation
between the length of the BT and the potency against the bacterium. Although S.
aureus bacteria have only one cell membrane, there is also a thick layer of
peptidoglycans on the exterior of the cell to contend with. As previously
mentioned, the peptidoglycan structure of Gram-positive bacteria can be up to 80
nm, however, the peptidoglycan layer in S. aureus is known to be approximately
20-30 nm thick. [16] In either case, the thickness of the cell envelope of the
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bacterium is far greater than the estimated length of our longest BT. This again
poses the question of how the BTs might be disrupting the cell membrane.
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3.4 Efficacy against MDR Bacteria
Following the various successes of the BTs against the E. coli (K-12) and
the methicillin-resistant S. aureus (BAA-1720) bacteria, it was decided that the
efficacy of the compounds against a multi-drug resistant (MDR) bacterial strain
would be investigated. MDR bacteria may have a plethora of antibiotic resistance
mechanisms. In addition to the cell membrane, many bacteria achieve resistance
through the development of efflux pumps. Efflux pumps are efficient as extrusion
of the antibiotic/toxin from the cell can occur before any damage has been
exerted on the bacterium. [17] Approximately 70% of methicillin-resistant S.
aureus bacteria are known to possess efflux pumps. [18] It is speculated that the
bactericidal properties of the BTs may be a result of pores in the bacterial
membranes caused by the BTs. Increasing membrane permeability may disrupt
ion homeostasis within the bacterial cell, which is essential for many cell
functions including utilization of efflux pumps. [19] If the BTs are disrupting cell
membranes and therefore disrupting ion homeostasis, it is suggested they might
also show potency against MDR bacteria.
In 2017, the WHO published a list of the bacteria for which new drugs
were needed most urgently. MRSA and MDR Gram-negative bacteria were both
included on the list. [20] The third bacterial strain against which antibiotic activity
of the BTs was screened was MDR E. coli (BAA-3058), a Gram-negative
bacterial strain. The results are shown in Table 3.3.
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Table 3.3 Minimum Inhibitory Concentrations (MICs) against MDR E. coli
Compound

MIC (µM)

C3BT

256

C4BT

512

C6BT

>1024

C8BT

32-64

C10BT

64-128

C12BT

>128

C14BT

>128

The efficacy of the BTs against MDR E. coli were generally poor and did
not follow the same trend observed for efficacy against the two other bacterial
strains. In this case, the most potent of the compounds was C8BT (MIC = 32-64
µM). The two BTs with the longest chains showed significantly lower potency
against the bacterium (MIC >128 µM). The compounds with shorter hydrocarbon
chains, C3BT, C4BT and C6BT were also less potent against the MDR E. coli than
the C8BT. The MIC for the C10BT was 64-128 µM, which was similar to the MIC
observed for C8BT.
Although there is no obvious trend in the results obtained for the BTs
against MDR E. coli, there is evidence of modest activity against this strain in the
micromolar concentration range. The ability of the C8BT and C10BT to impede the
growth of the MDR E. coli at all suggests the bacterial cell’s integrity or essential
functions have been disrupted by the BTs.
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3.5 Conclusion
Throughout the bacterial studies, it was hoped that the compounds would
show efficacy against bacteria in the low micromolar concentration range, well
below 128 µM. The C3BT, C4BT and C6BT were inactive at MICs below 128 µM
against any of the three bacterial strains. The C8BT, C10BT, C12BT and C14BT all
showed activity below 128 µM for at least two of the three bacteria used for
screening. Among the compounds tested, only C10BT showed activity against all
three bacterial strains.
The C12BT and C14BT are the compounds with the longest hydrocarbon
chains. They each were potent against Gram-negative and Gram-positive
bacteria, with MICs of 12 µM (±4 µM) or lower. Surprisingly, both compounds
failed to show activity below 128 µM against the MDR E. coli bacteria. In
contrast, the C8BT, which had a MIC of 128 µM against the Gram-negative E. coli
(K-12) strain, showed the most potency of all the BTs against the MDR E. coli
strain (MIC = 32-64 µM). This could be explained in number of ways. The
mechanism of action of the C8BT may be different than the C12BT and C14BT.
The efflux pump of the MDR E. coli might be capable of extruding the C12BT and
C14BT, but not the C8BT. The C8BT may block the efflux pumps, whereas C12BT
and C14BT might not. C8BT might form aggregates capable of disrupting the
membrane of the MDR E. coli, which are relatively incapable of disrupting the
membrane of the K-12 E. coli. Bacteria and cell membranes can be incredibly
complex, so all of these possibilities remain speculative.
The compound that showed consistent activity against all three bacterial
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strains was C10BT. This may suggest it has the greatest potential against a range
of bacteria. It was not, however, the most potent against any of the individual
strains of bacteria.
The differences observed in the potency of the BTs against all three
bacterial strains is interesting. A mechanism of action can be hypothesized. In
earlier work by the Gokel group, BTs were shown to form pores in bilayer
membranes. [7] In addition, the Gokel group had previously demonstrated E. coli
cell membrane disruption , using fluoresceine diacetate (FDA) and propidium
iodide (PI). Confocal microscopy was used to show the cell membrane was
compromised in the presence of either m-PhBT or C12BT at ½ MICs. PI does not
normally pass through the membrane into E. coli cells, yet could be detected, via
fluorescence, intercalated with DNA within the cell. [15] Penetration of the cell
membrane is made possible by BTs.
Pores or channels in the cell membrane can disrupt ion homeostasis. As
mentioned previously, ion homeostasis is essential for many cell functions,
including the function of efflux pumps. [19] [21] Therefore, membrane disruption
caused by the BTs could result in biological activity, including activity against
antibiotic resistant bacterial strains. The length of any of the individual BTs is
known to be too short to span any of the membranes or envelopes. Pores or
channels, if they exist, must be formed by aggregation or organization of the
molecules at the cell membrane.
Antimicrobial peptides (AMPs) commonly facilitate bacterial cell death by
disrupting cell membranes or hindering other functions essential for cell survival.
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[22] AMPs may promote bacterial aggregation or may indeed self-associate and
form aggregates of their own. [23] AMPs most often are known to self-aggregate
when they are rich in arginine (Arg) and tryptophan (Trp) residues, due to the
cation-π and π-π stacking interactions. The BTs are rich in tryptophan by design.
In all cases where AMPs are bactericidal, they first interact and interfere with the
inner and / or outer cell membrane(s) of the bacterium. [24]
There are a number of ways in which AMPs may form aggregates while
interacting with the cell membrane. Fig. 3.5 shows various models of such
modes of aggregation which may occur for AMPs. These aggregation models
facilitate bactericidal activity. [24]
The diagram at the top, left-hand side of Fig. 3.5 shows AMP molecules
bound parallel to the lipid membrane. This typically happens at low peptide / lipid
ratios (low concentrations of AMP). As the concentration of the AMP is
increased, the peptide orients perpendicular to the lipid membrane, inserts into
the membrane and forms pores or channels (known as the I state). Peptide / lipid
ratios, along with a host of other factors influence the types of pores or channels
that are formed. [25]
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Figure 3.5 Five different models describing AMP activity at cell membranes.
(A) Barrel-Stave Model. (B) Carpet Model. (C) Toroidal Pore Model. (D)
Molecular Electroporation Model (E) Sinking Raft Model. Schematic
produced by Vogel et al. [24]
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Model A shows the barrel-stave mode of aggregation. This is one of the
most common aggregation types and is seen in the widely studied ionophore,
alamethicin (Alm) (Acetyl-Aib-Pro-Aib-Ala-Aib-Ala-Gln-Aib-Val-Aib-Gly-Leu-AibPro-Val-Aib-Aib-Glu-Gln-phenylalaninol) (Fig. 3.6). In this model, the peptide
helices bundle together in the membrane and a central lumen forms. The lumen
represents the barrel held together by the peptide “staves.” The hydrophobic
regions of the peptide match up with the core lipid region of the membrane and
the hydrophilic regions of the peptide form the interior of the newly formed
membrane pore. Alm pores of this nature have channel walls (staves)
approximately 1.1 nm thick. [25]
In 1993, the Parsegian group established that the difference in lipids found
in the membranes greatly varied the activity of the membrane channels formed
by alamethicin. [26] It was noted that the concentration of the compound required
to form channels in the first place could vary by 10-fold. There was a striking
difference not only in the activity of the channels formed, but whether the
channels formed at all when the lipids of the membrane were varied. It is
proposed that the differences in channel formation and activity can be associated
with the repulsive forces of the head groups in the phospholipid bilayer and a
disparity that may exist in terms of hydrophobicity among thicker vs. thinner
membranes with the aggregates. [27]

96

Figure 3.6 Chemical structures of Alamethicin (left) [30] and melittin (right) [31]

Model B in Fig. 3.5 shows the carpet-model. This occurs when AMPs
accumulate on the surface of the membrane, orienting parallel to the surface.
Ovispirin (NH2-Lys-Asn-Leu-Arg-Arg-Ile-Ile-Arg-Lys-Ile-Ile-His-Ile-Ile-Lys-Tyr-GlyCOOH) is an example of an AMP that aggregates this way. There is electrostatic
attraction between the anionic phospholipid head groups and the peptide. At
higher concentrations, the peptides disrupt the membrane in a similar manner to
detergents and form micelles. This allows for holes to occur in the membrane,
allowing more peptides to interact with the membrane and to form more micelles.
Eventually, the membrane has been disintegrated entirely. [25]
Model C in Figure 3.4 shows the toroidal-pore model, often resulting from
interactions of membranes with protegrins or melittin (NH2-Gln-Gln-Arg-Lys-ArgLys-Ile-Trp-Ser-Ile-Leu-Ala-Pro-Leu-Gly-Thr-Thr-Leu-Val-Lys-Leu-Val-Ala-GlyIle-Gly-COOH) (Fig. 3.6). The AMPs insert into the membrane causing the layers
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of the membrane to bend. This opens up an aqueous core surrounded by both
the peptide and the phospholipid head groups. The polar regions of the AMPs
associate with the polar regions the phospholipid head groups. This orientation
allows for cationic peptide charges to be masked. [25]
Model D is somewhat different than the previous three models. It
represents molecular electroporation. The association of cationic peptides with
the negatively charged bacterial membrane can produce an electrical potential. It
is proposed that when a membrane potential difference is greater than 0.2 V,
pores form and the membrane is compromised. [24] Although the BTs are likely
protonated at the two primary nitrogen atoms, this is not entirely sufficient for the
electroporation model to be relevant.
The final model described, Model E, represents the sinking raft model. In
this model, the amphiphile, AMP, integrates into and binds with the cell
membrane. The binding causes an imbalance in terms of mass and so the
membrane begins to bend and bow. This allows the AMP molecules to selfassociate and create pores within the cell membrane. [28]
At this time, the mechanism of antimicrobial action of any of our
compounds against the three bacteria remains unclear. The high proportion of
tryptophan residues in the BTs suggests that self-association and the formation
of aggregates is viable. It is also possible that these properties allow the
formation of pores or channels through the cell membrane(s). Planar bilayer
conductance has been observed for several of the BTs in phospholipid bilayer.
To be sure, these bilayers are far simpler than any bacterial boundary layer, but
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these results are suggestive of membrane penetration. The next section of this
research will investigate some of the properties of BTs further using dynamic light
scattering (DLS), scanning electron microscopy (SEM) and UV-Vis spectroscopy.
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3.6 Experimental Details
3.6.1 Bacterial Strains Used. The K-12 E. coli (ATCC 700926), S. aureus
(BAA-1720) and MDR E. coli (BAA-3058) were all purchased from American
Type Culture Collection (ATCC). All bacterial strains were grown in Mueller
Hinton II (MHII) media (Sigma-Aldrich).
3.6.2 MIC Experiments. MIC experiments were performed according to the
Clinical and Laboratory Standards Institute protocols for microdilutions. [5] The
bacteria from one colony-forming unit (CFU) were grown overnight (18-20 hours)
at 37 °C, in MHII media. The next day, the media are knocked back to O.D. at λ =
600 nm = 0.500 in the same media. The bacteria, now in the exponential growth
phase, are diluted in the media to achieve 4x108 CFU / mL. The 96-well plates
were set up according to Fig 3.2 using MHII media and the serially diluted BT
compounds. The BT compounds were dissolved in DMSO with the final DMSO
concentration in each well-kept constant at 0.5% (v / v). The contents of the wells
were mixed thoroughly before the cells were added (20 µL giving 4x10 5 CFU /
mL per well). The plates were incubated (37 °C, 200 RPM, 20 hours) and the
results collected on the Biotek Cytation 3 plate reader. O.D was determined at λ
= 600 nm. Media alone was considered as 100% inhibition and cells with media
considered 0% inhibition. Inhibition greater than 90% was considered the MIC for
that compound. All results were duplicated and then reproduced three times
before reporting.
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Chapter 4
Characterization of Properties of Bis(Tryptophan) Amphiphiles
4.1 Introduction
Following the successful outcomes of the bis(tryptophan) amphiphiles
(BTs) against the three bacterial strains, the interest in the potential mechanisms
of action of these compounds was piqued further. Commonly proposed
mechanisms of antimicrobial peptides (AMPs) include disruption of cell
membrane structures, hindrance of cell membrane functions or indeed
penetration into the cytoplasm of the bacterial cell and subsequent targeting of
organelles and functions within the cell (Fig. 3.4). [1] [2] AMPs are also known to
promote bacterial cell death by facilitating bacterial aggregation. [3] Furthermore,
AMPs rich in tryptophan (Trp) and arginine (Arg) residues are known to readily
self-associate. The cation-π and π-π stacking capabilities allow for the formation
of various aggregates and nanostructures. [2] It was therefore decided that the
potential aggregation of the BTs should be explored. Dynamic light scattering
(DLS) is a method that will detect the presence of aggregates. If they are
present, aggregate size is also estimated. Detection of aggregation can then be
confirmed via scanning electron microscopy (SEM). SEM would also allow for the
shape of aggregates to be observed.
The Gokel group has developed hydraphiles that act as ion channels once
inserted into bacterial cell membranes. [4] [5] They have also developed lariat
ethers that can act as ion carriers when donor groups are present in the side
arms. The lariat ethers can also form pores in cell membranes in the absence of
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donor groups. [6] The Gokel group has previously conducted planar bilayer lipid
membrane (BLM) studies on BTs (Fig. 4.1) This trace shows classical openclose behavior with two stable open states observed. It is possible that two open
channels formed or that aggregate formation was observed of the BT. It should
be stated that this experiment involves passage of ions across a synthetic
membrane and is not conducted within a bacterial cell. At least two of the BTs
[ortho-C6H4(L-Trp)2∙2HCl and meta-C6H4(D-Trp)2∙2HCl] displayed ion channel
activity. [7]

Figure 4.1 Planar bilayer voltage clamp trace produced by the Gokel
lab for m-PhBT [meta-C6H4(D-Trp)2∙2HCl] in azolectin bilayers. Voltage
applied = 30 mV, 10 mM HEPES buffer, [KCl] = 450 nM [7]

The maximal length of any of the BTs is significantly shorter than the cell
envelope of the bacterial strains used in this work. If the BTs are active via the
mechanism observed in the BLM study, it is likely that the BTs form these
channels by some type of self-assembly
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4.2 Dynamic Light Scattering (DLS)
4.2.1 Introduction to DLS. Dynamic light scattering is used to determine
the effective diameter (Z-diameter) of particles in solution. The Z-diameter is the
average diameter size detected of all aggregates detected in the sample at that
time. Theoretically, the hydrodynamic diameter (dh ) of a particle in solution is
inversely related to the rate of diffusion, according to the Stokes-Einstein
equation: Dt = Kb T / 3πηdh, where Dt is the translational diffusion coefficient, Kb
is the Boltzmann constant, T represents the temperature, and η is the viscosity of
the bulk solution. [8]
The DLS instrument operates by projecting monochromatic light into the
sample at a 90° angle. The scattered light is collected and transformed into an
autocorrelation function, which is then used to determine the size distribution.
There are a number of limitations to the application of DLS. The limitations that
are important for this research include maintaining a constant temperature and
recognizing that the instrument operates at low resolution and therefore cannot
distinguish between closely related molecules (for example, monomers and
dimers). The instrument is also sensitive to dust particles, thus minimizing the
exposure to dust is of paramount importance. The steps taken to reduce the
impact of dust particles are detailed in the experimental section. [8] DLS
measurements were obtained for all of the BTs in the library used and developed
in this research.
4.2.2 DLS Results and Discussion. The initial library of BTs synthesized
by the Gokel lab yielded several biologically active compounds. Among those
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was the C12BT [(CH2)12(L-Trp)2∙2HCl]. This compound was the most potent of the
BTs and more data has been accumulated for this compound than any of the
other BTs. It was decided that exploration of the aggregation of the BTs should
start with C12BT.
At the beginning of the DLS investigations, the amount of time used for the
collection of data was arbitrarily assigned at 30 minutes. It was noted that the
size of aggregates forming continued to increase with time. It was important, from
a chemical standpoint, to establish a timeframe within which the maximal size of
aggregates could be determined. It was found that within a four-hour window, the
aggregation size usually stabilized, and a maximal aggregation size could be
established. This four-hour aggregation window is more chemically than
biologically relevant. Consequentially, the DLS experiments for all BTs were
conducted for four hours. The data depict the Z-diameter of the particles detected
in the solution.

Figure 4.2 Aggregation of 128 µM C12BT [(CH2)12(L-Trp)2∙2HCl] over 4 hours in
PBS solution. A Logarithmic trendline (blue) and linear trendline (grey) are shown.
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The results for the aggregation of 128 µM C12BT in phosphate buffered
saline (PBS) solution over 4 hours can be seen in Fig. 4.2. PBS solution was
chosen as the initial solvent as it most closely mimics physiological conditions.
The results show that the Z-diameter of the aggregates formed increases over
time and continued to increase to a maximum size of 1300 nm achieved at 240
minutes. This data suggested that some aggregates could be as large, or even
greater in size than the bacterial cells used (E. coli are approximately 3000 nm
long and 1000 nm in diameter). [9] The increase in aggregation size over time is
not unique to BTs. Proteins, such as monoclonal antibodies, in a buffer solution
will also aggregate over time. [10] It is important to acknowledge that the Zdiameter is an average measurement based on the sizes of all particles detected.
Many smaller molecules and aggregates will undoubtedly exist which may be
more important for biological activity than the aggregates which are larger than
the bacterial cell. We speculate that these smaller aggregates may interact with
the bacterial surface, perhaps inserting into the lipid membrane, causing
disruption or pore formation.
Various trend lines were applied to the data in Fig. 4.2. The linear
trendline (grey) and a logarithmic trendline (blue) are shown. A linear relationship
exists when there is a steady increase in the aggregate sizes over time. A
logarithmic relationship exists when there is a sharp increase in the aggregate
sizes, which then levels off over time. The coefficient of determination (R 2) was
calculated for each trend. An R2 value of 1 indicates that the trendline perfectly
fits the data. The R2 for the linear fit was 0.86, however the R2 for the logarithmic
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trendline was significantly better, 0.993. The logarithmic trendline was the best fit
for the relationship between aggregation size and time for all of the BTs in PBS in
this study. The aim of the longer trial time for the DLS studies was to determine
when a maximal aggregate size was achieved. The DLS data show that there is
a fast increase in aggregate size observed initially but over sufficient time, the
aggregate sizes no longer increase beyond a certain point.
The biological activity of the C12BT, and the other BTs, is based upon the
concentration of compound to which the bacteria are exposed. DLS data were
collected to find if changing concentration of C12BT had any impact on the size of
aggregates formed, as shown in Fig. 4.3.

R2 = 0.995

Z-Diameter (nm)

128 µM
80 µM

32 µM
8 µM

Concentration (µM)

Figure 4.3 Effect of concentration on the size of aggregates formed of C12BT
[(CH2)12(L-Trp)2∙2HCl] over 4 hours in PBS solution.
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The concentration range studied was from 8 µM – 128 µM, to reflect the
concentrations at which the C12BT was biologically active. There is a linear
relationship between concentration and the Z-diameter of aggregates with an R2
value of 0.995. This linear relationship shows that as the concentration
increases, so too does the average size of aggregates formed. This is the
expected relationship between concentration of BTs and the size of aggregates
formed. Increasing the concentration of the BT in solution facilitates increased
probability of collisions and, therefore, aggregates are likely to form larger sized
molecules. [10]
In addition to investigating the aggregation of C12BT in PBS solution,
aggregation was also monitored for the compound in 18.2 MΩ H2O and in MHII
(Mueller Hinton Broth II) media (Fig. 4.4).

Z-Diameter (nm)

PBS

MHII Media

18.2 MΩ H2O

Time (min)
Figure 4.4 Effect of solvent on the size of aggregates formed from 128 µM
C12BT [(CH2)12(L-Trp)2∙2HCl] as a function of time.
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The DLS studies for C12BT in de-ionized water showed no evidence for
aggregation. Within two hours, aggregates over 1000 nm in diameter were
observed in the PBS solution, whereas no aggregation was detected during the
same time in 18.2 MΩ H2O. This suggests that the ions present in the PBS
solution (Na+, K+, Cl-, [HPO4]-, [H2PO4]2-) may contribute to the amphiphile’s
ability to form sizeable aggregates. The BTs may coordinate around the ions. For
example, the positively charged ions may coordinate with indole groups from the
tryptophan residues. It is also possible the NH3+ coordinates with anions in
solution. Aggregation may depend on interactions such as these occurring
between “layers” of amphiphiles.
When the MHII media, consisting of meat extract, casein hydrolysate and
starch, was used instead of PBS solution, aggregates of about 350 nm in
diameter were observed. MHII media also contains many ions (including Na+, H+,
Cl-, CH3CH(OH)COO-). It was expected that the C12BT in MHII would form
aggregates due to the presence of these ions. Over the 4-hour timeframe, the
aggregates formed did not increase in size. The 350 nm size is significantly
smaller than the 1300 nm diameter observed in PBS solution. One reason may
be the viscosity of the media solution compared to the PBS. In a more viscous
solution, it may be reasonable to observe aggregates forming over a longer time
period. [10] The MHII media contains a vast array of molecules compared to the
PBS solution. The presence of starch, various amino acids and many other
organic and inorganic materials common to meat extracts, will impact the
viscosity, availability of ions and presumably the aggregation rate of C12BT
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amphiphiles. To investigate this further, DLS measurements were taken of the
C12BT in MHII media over a 2-week time period, Fig. 4.5. The objective of the
longer aggregation window was to determine if a similar maximal aggregation
size would be observed over a longer time period as the viscosity of the media
was thought to be slowing the rate of aggregation.

Z-Diameter (nm)

R2 = 0.998

R2 = 0.957

Time (hour)
Figure 4.5 Aggregation of 128 µM C12BT [(CH2)12(L-Trp)2∙2HCl] in MHII media
solution over 2 weeks.

The aggregate growth trend for C12BT in MHII media most closely
matched an exponential growth trend (R2 = 0.998). The Z-diameter of the
aggregates reached over 1600 nm after two weeks. In PBS solution, the C12BT
reached a comparable 1300 nm Z-diameter size after four hours. The concave
curve is a result of the exponential increase in aggregate size over two weeks.
This is an unexpected trend. The aggregate formation in PBS solution was much
quicker initially, reaching a maximal Z-diameter within four hours. Therefore, a
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convex curve was observed as a plateau was reached for the C12BT in PBS
solution .The aggregation curve for the C12BT in MHII media (Fig 4.5) suggests
that the viscosity of the media led to slower rates of aggregation but did not
prevent aggregation. A slower rate of aggregation does not explain an
exponential growth curve. It would be expected that the trend may be linear. As
the rate of aggregation was decreased due to viscosity, the rapid increase in
aggregate size would not be observed. Instead, a steady increase in aggregate
size would be expected until a maximal aggregate size is observed. A concern in
this case is that the MHII media containing the amphiphile is not entirely
transparent. A lack of transparency of the solution can prevent the DLS
instrument from accurately determining the size of the aggregates. [8] It is
therefore suggested that the media does indeed facilitate aggregation of the
C12BT at a slower rate, but the size of aggregates may be obscured by media
particulates. Obtaining aggregate sizes between 144 hours and 336 hours (one
week and two weeks) might have helped understand the rate of aggregation and
the trendline observed. Those additional data points could help determine if the
growth trend was more linear or if the convex trend was more accurate.
The next logical step in the utilization of DLS was investigating if
aggregation could be observed for any other BTs. The C8BT, C10BT and C14BT
were all biologically active. DLS was used to explore any potential aggregation in
PBS solution for each of these BTs.
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The DLS experiments for C8BT in PBS showed that aggregates did form
over 4 hours. Fig. 4.6 shows that an effective aggregate diameter as large as
2700 nm was observed for C8BT at 128 µM concentration over this time period.
The maximal Z-diameter for C8BT is twice that of the C12BT (1300 nm). This
shows that the length of the hydrocarbon chain of the amphiphile has an impact
on the size of aggregates being formed. It is speculated that the way in which the
C8BT and longer chain BTs are aggregating is different. It is speculated that the
C12BT folds and so both the tryptophan residues are at the same “end” while in
shorter chains, such as C8BT, the chain may not fold. Both C12BT and C8BT are
active against both Gram-negative and Gram-positive bacteria, however, C12BT
is more potent in the MIC studies conducted in this research. For example, C12BT
has a MIC of 12 µM (± 4 µM) against E. coli (K-12), whereas the MIC of C8BT for
the same bacterial strain is 128 µM. Similarly, while C8BT has a MIC of 50 µM (±
18 µM) against MRSA, the MIC of C12BT is significantly lower at 6 µM (± 2 µM). It
appears that while aggregation may enhance the antimicrobial effects of these
amphiphiles, larger aggregates may not suggest greater potency. As mentioned
previously, the larger aggregates may be too large to have any biological effect.
The number of smaller aggregates formed may be more relevant to biological
activity as they may be capable of disrupting the bacterial cell membranes.

115

Z-Diameter (nm)

R2 = 0.946

Time (min)
Figure 4.6 Aggregation of 128 µM C8BT [(CH2)8(L-Trp)2∙2HCl] over 4
hours in PBS solution

The aggregation of C8BT follows a similar trend to C12BT when
concentration is varied. Fig. 4.7 shows that increasing the concentration of C8BT
leads to an increased Z-diameter of the aggregates formed. Unlike the C12BT, at
8 µM, the C8BT does not form any aggregates, whereas the C12BT forms
aggregates with diameters greater than 200 nm at 8 µM (Fig. 4.3). Fig. 4.7
shows that aggregates are observed at 32 µM C8BT, suggesting the critical
aggregate concentration (CAC) of the C8BT is greater than 8 µM but less than 32
µM (8 µM < CAC < 32 µM). Interestingly, no antibacterial activity was observed
below 32 µM. This was true for both Gram-positive and Gram-negative strains.
The data comport with the suggestion that aggregation may be linked to the
antimicrobial properties of the bis(tryptophan) amphiphiles.
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R2 = 0.959

Z-Diameter (nm)

80 µM

128 µM

32 µM
8 µM

Concentration (µM)
Figure 4.7 Effect of concentration on the size of aggregates formed of
C8BT [(CH2)8(L-Trp)2∙2HCl] over 4 hours in PBS solution.

The C10BT aggregates formed in PBS solution (~1500 nm) were more
similar in size to the C12BT (1300 nm at 128 µM), than the C8BT aggregates
(2700 nm at 128 µM) (Fig. 4.8). The data show that the aggregate sizes of 128
µM C10BT in PBS solution increase over time, reaching a plateau during four
hours. This trend is similar to the one observed for C12BT (Fig. 4.2) and C8BT
(Fig. 4.6).
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Z-Diameter (nm)

R2 = 0.984

Time (min)
Figure 4.8 Aggregation of 128 µM C10BT [(CH2)10(L-Trp)2∙2HCl] over 4
hours in PBS solution.

The relationship between the concentration and the Z-diameter of the
aggregates of C10BT was also investigated by DLS. Fig. 4.9 shows the
increasing aggregate size as the concentration of the amphiphile is increased. In
this system a linear relationship also exists between concentration and the size
of the aggregates formed. At 8 µM the C10BT forms large aggregates. The C10BT
falls between the C8BT and C12BT in terms of chain length. Aggregates were not
detected until 32 µM for C8BT (Fig. 4.7), however the C12BT showed clear
aggregation from 8 µM (Fig. 4.3). The lowest MIC observed for the C10BT against
E. coli was 32 µM, however the MIC against the Gram-positive MRSA bacterium
was as low as 16 µM.
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R2 = 0.989

Z-Diameter (nm)

128 µM

80 µM
32 µM
8 µM

Concentration (µM)
Figure 4.9 Effect of concentration on the size of aggregates formed of
C10BT [(CH2)10(L-Trp)2∙2HCl] over 4 hours in PBS solution.

The C14BT was biologically active against E. coli (K-12) at 8 µM in these
studies. DLS was used to determine the sizes of aggregates formed from C 14BT
in PBS solution. The maximal Z-diameter of aggregates at 128 µM is
approximately 1600 nm (Fig. 4.10). These aggregates are again significantly
smaller than the aggregates observed for the C8BT (2700 nm at 128 µM). It is
notable that the C10BT, C12BT and C14BT all form aggregates of a more similar
size than the C8BT, at 128 µM in PBS solution.
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Z-Diameter (nm)

R2 = 0.959

Time (min)
Figure 4.10 Aggregation of 128 µM C14BT [(CH2)14(L-Trp)2∙2HCl] over
4 hours in PBS solution.

Further DLS studies were carried out on the C14BT to investigate any
relationship between concentration and the Z-diameter of the aggregates formed,
(Fig. 4.11). The results were consistent with previous results for the aliphatic
BTs. As the concentration of C14BT in solution is increased, the size of the
aggregates formed also increases. Significantly large aggregates were again
observed at concentrations as low as 8 µM. The MIC for C14BT against E. coli (K12) is 8 µM and the MIC against MRSA is as low as 4 µM.
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Z-Diameter (nm)

R2 = 0.970

Concentration (µM)

Figure 4.11 Effect of concentration on the size of aggregates formed of
C14BT [(CH2)14(L-Trp)2∙2HCl] over 4 hours in PBS solution.

From the DLS data collected from the aliphatic bis(tryptophan)
amphiphiles, it is evident that each of the compounds form aggregates in PBS
solution. It is also apparent that increasing the concentration of any of the BTs in
solution leads to larger aggregates being formed, Fig. 4.12.
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Z-Diameter (nm)

C8BT

C14BT
C10BT
C12BT

Concentration (µM)
Figure 4.12 Effect of concentration on the size of aggregates formed of C8BT
[(CH2)8(L-Trp)2∙2HCl], C10BT [(CH2)10(L-Trp)2∙2HCl], C12BT [(CH2)12(L-Trp)2∙2HCl]
and C14BT [(CH2)14(L-Trp)2∙2HCl] over 4 hours in PBS solution.

The C8BT, C10BT, C12BT and C14BT all showed activity against at least
two of the three bacterial strains investigated, at concentrations below 128 µM.
These four compounds also all formed aggregates >1000 nm in diameter at
concentrations of 128 µM or lower. The complexity of the cell membrane and its
potential interactions with aggregates of other amphiphilic molecules, cannot be
overstated. Three model systems, mentioned in Chapter 3, describing the
potential interactions of AMPs with bacterial cell membranes, exemplified the
possible methods of pore and channel formation. The barrel-stave, carpet, and
toroidal-pore models are all possible mechanisms by which the BTs could be
inserting into and disrupting bacterial cell membranes. [2] [11] [12] Important
physical attributes for compounds to be capable of these mechanisms include
amphiphilicity and the capability to engage in electrostatic interactions. The BTs
are short chained amphiphiles that have been synthesized as hydrochloride
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salts.
Two further mechanisms of action for AMPs were also previously
described. The molecular electroporation and sinking raft models could be
mechanisms by which the BTs express biological activity. [2] [13] Again, the
ability to form electrostatic interactions with anionic species in the cell membrane
and being amphiphilic in nature, would allow the BTs to potentially interact with
the cell membrane by either of these two mechanisms. The tryptophan-rich
nature of our small molecules may also encourage aggregation and facilitate
membrane activity due to potential cation-π or π-π stacking. Fig. 4.13 shows
representative π stacking conformations for non-polar (A,B) and polarized (C) πsystems. [14]

Figure 4.13 Schematic showing potential π stacking interactions of nonpolar benzene rings (A and B) and polarized π-systems (C). Image
created by Li et al. [14]
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It is suggested that the indole groups of the tryptophan residues of the
BTs are involved in π-cation-π stacking interactions, thus facilitating aggregation.
Tryptophan residues are known to be involved in stacking with other ring systems
and favor perpendicular ring interactions and a staggered stacking structure in
proteins. [15] [16] When interactions of the tryptophan indole ring with the
aromatic side chains of other tryptophan residues, histidine, tyrosine, and
phenylalanine were analyzed, parallel packing was only observed 11% of the
time. [16] The interaction of central negative charge of the ring system and the
partial positive charges of hydrogens is one of the most simplistic explanations
for stacking being observed and the specific spatial orientation of stacking [15]
However, there was no aggregation observed in the absence of ions (Fig 4.4),
when aggregation of C12BT was measured in 18.2 MΩ H2O. It is therefore
suggested that π-cation-π stacking interactions may be taking place.
Having established an apparent correlation between aggregation and
biological activity, it was important to investigate if any of the biologically inactive
BTs (MIC > 128 µM) also aggregated. C4BT was chosen as the first biologically
inactive compound to be investigated for aggregation, Fig. 4.14. The DLS data
collected of 128 µM C4BT in PBS control solution over 4 hours showed that no
aggregates were forming. The 6-8 nm Z-diameter is what is observed for PBS
solution alone. The only difference in the C4BT structure compared with the
biologically active BTs, is the shorter chain length compared to active
compounds. It appears that the linker must be of a particular length to facilitate
aggregation. It also seems that aggregation correlated to antibacterial activity.

124

Z-Diameter (nm)

R2 = 0.001

Time (min)
Figure 4.14 Aggregation of 128 µM C4BT [(CH2)4(L-Trp)2∙2HCl] over 4
hours in PBS solution.

DLS data were also collected for 72 hours for the C4BT, to ensure that
aggregation was not happening at a slower rate. Fig. 4.15 shows that there was
no increase in the Z-diameter observed during this time, confirming a lack of

Z-Diameter (nm)

aggregation.

R2 = 0.064

Time (min)
Figure 4.15 Aggregation of 128 µM C4BT [(CH2)4(L-Trp)2∙2HCl] in PBS
solution after 72 hours.
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Although the longer-chain aliphatic BTs did not aggregate in 18.2 MΩ
H2O, an experiment was conducted to determine if the shorter-chain C4BT
behaved differently or not, Fig. 4.16. Over the course of 1 hour, no aggregates ≥
8 nm were detected. For all the compounds that showed aggregation, DLS
detected it almost instantly and certainly within the first 24 minutes. No

Z-Diameter (nm)

aggregation was detected for the C4BT, either in PBS solution or 18.2 MΩ H2O.

R2 = 0.132

Time (min)
Figure 4.16 Aggregation of 128 µM C4BT [(CH2)4(L-Trp)2∙2HCl] in
18.2 MΩ H2O solution over 1 hour.

DLS data were next collected for the C3BT. This compound showed no
biological activity in the three-organism screen discussed above. It has a shorter
carbon chain than any of the other BTs investigated up to this point. It was
therefore expected that no aggregation would be detected for the C 3BT in PBS
solution. Fig. 4.17 shows the data obtained for 128 µM C3BT in PBS solution
over 100 minutes. As expected, there was no aggregation detected for the C 3BT
in PBS solution.
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Z-Diameter (nm)

R2 = 0.149

Time (min)
Figure 4.17 Aggregation of 128 µM C3BT [(CH2)3(L-Trp)2∙2HCl]
over 100 minutes in PBS solution.

The remaining aliphatic BT compound from this library is C6BT. The chain
length lies between that of the biologically inactive C4BT and the active C8BT.
DLS was used to collect potential aggregation formation in PBS solution over 4
hours, Fig. 4.18. Similar to the other biologically inactive compounds, C3BT and
C4BT, the C6BT shows no signs of aggregate formation over 4 hours in PBS
solution.
Based on the biological and DLS data collected for the aliphatic BTs, it
can be concluded that the biologically active BTs (C8BT, C10BT, C12BT and
C14BT) all form aggregates in the PBS solution. Similarly, it can also be
concluded that the biologically inactive compounds (C3BT, C4BT and C6BT) do
not form aggregates in the PBS solution. The length of the carbon chain in the
compounds appears to dictate formation of aggregates and biological activity
against the three bacterial strains investigated. It is possible that the hydrocarbon
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chain needs to be of a certain length to allow for the flexibility for π-π stacking, or

Z-Diameter (nm)

other mechanisms of aggregation.

R2 = 0.131

Time (min)
Figure 4.18 Aggregation of 128 µM C6BT [(CH2)6(L-Trp)2∙2HCl] over
4 hours in PBS solution.

In previous work conducted by the Gokel lab, phenylene-linked BTs also
showed potency against multiple bacterial strains. [7] The maximal length of any
of these compounds is estimated to be ~9 Å, approximately 25% shorter than the
C12BT (~12 Å) and a similar length to the C3BT and C4BT. [7] DLS experiments
were conducted for the m-PhBT [meta-C6H4(L-Trp)2∙2HCl] and p-PhBT [paraC6H4(L-Trp)2∙2HCl], Fig. 4.19. On this occasion, the experiments were conducted
over three hours instead of four. A plateau in aggregate size was reached more
quickly for each of the phenylene-linked BTs than the aliphatically-linked BTs.
Despite their biological activity, (MIC = 64 µM and 128 µM against K-12 E. coli for
m-PhBT and p-PhBT respectively), it was expected, based solely on their short
chain length, the two phenylene-linked BTs would not form aggregates. Of
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course, the phenylenes are fundamentally different than the CnBTs.
The DLS data showed that both the m-PhBT and p-PhBT formed
aggregates in PBS solution. The p-PhBT formed larger aggregates overall, with a
maximal Z-diameter over 1300 nm, comparable to the aggregates seen for
C12BT. The m-PhBT formed aggregates about half as large, with a maximal Zdiameter of less than 800 nm.
R2 = 0.88

Z-Diameter (nm)

p-PhBT

m-PhBT
R = 0.92
2

Time (min)
Figure 4.19 Aggregation of 128 µM m-PhBT [meta-C6H4(L-Trp)2∙2HCl] and pPhBT [para-C6H4(L-Trp)2∙2HCl] over 3 hours in PBS solution.

The data suggest that the length of the molecule may be less important
than the ability to form π-π or π - cation - π stacking interactions. It is possible
that the short-chain aliphatic BTs are unable to form aggregates as the
hydrocarbon chain does not allow for enough rotation to self-assemble. While the
phenylene linker may be similar in length to the linker of the C3BT and C4BT, the
phenylene-linked BTs appear to be able to aggregate. It is known that the indole
group of the tryptophan interacts favorable with other ring systems. [15] [16] The
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phenyl ring in the linker could promote π-π or π - cation - π stacking interactions
(Fig. 4.13), thus forming aggregates.
The aggregation data from the phenylene-linked BTs do not correlate with
the biological activity. The p-PhBT forms larger aggregates than the m-PhBT,
however it is less active against E. coli (K-12) than the m-PhBT. It is unsurprising
that aggregation size in PBS solution and the biological activity are not
proportional. It is speculated that smaller aggregates may be integrating with the
membrane and so the ultimate size of potential aggregates may not be relevant.
The stability of the aggregates formed and their ability to integrate into the cell
membrane are likely more important factors. It is also known that the composition
of the cell membrane, along with other factors, will impact how the BT will interact
with the bacterial cell. [11] [12] For example, the net charge at the membrane can
prevent AMPs and other molecules penetrating. S. aureus is known to transport
D-alanine

from the cytoplasm to the membrane to reduce the net negative charge

near the membrane surface. Increased hydrophobic interactions can also prevent
penetration into the cell. Salmonella species are capable of increasing the
hydrophobic interactions between Lipid A acyl tails which reduces the fluidity of
the membrane, making it more difficult to penetrate. [11]
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4.3 Scanning Electron Microscopy (SEM)
4.3.1. Introduction to SEM. Scanning electron microscopy allows for the
size and shape of molecules to be determined. It can also provide information on
the surface topography and composition of the molecules. In SEM, the sample is
adhered to or coated with conductive material (if necessary) and mounted on the
stage. Within the microscope, a vacuum is produced, and the sample is
subjected to a focused electron beam. The vacuum allows for high quality
imaging, but also protects the electron source from noise and vibrations. The
sample is scanned by the electron beam in a raster pattern, interacting with the
atoms at the surface of the sample. Signals in the form of secondary electrons
and backscattered electrons are produced. These are collected and interpreted
by detectors and the images are produced on the screen. [17]

4.3.2 SEM Results and Discussion. Electron microscopy images were
taken to confirm the size of bis(tryptophan) aggregates determined by DLS, and
to investigate the shape of the molecules forming. The C12BT [(CH2)12(LTrp)2∙2HCl] was used for the initial images. Fig. 4.20 and Fig. 4.21 show the
SEM images collected of C12BT aggregates which were formed in PBS solution.
Before images were taken, they were dried and mounted on conductive carbon
tape.
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10 µM

Figure 4.20 Scanning Electron Micrograph of C12BT aggregates

Fig. 4.20 shows a great number of aggregates, many of which are
clustering and potentially fusing with one another to form larger structures, such
as the one shown at the bottom right-hand corner of the micrograph. The image
shows that holes, or pores, exist in some of the larger structures. This may be
indicative of the types of pores formed when the BT amphiphile interacts with the
cell membrane, although this is obviously speculative. The range of sizes and the
number of molecules was vast with all aggregates appearing spherical in shape.
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Figure 4.21 Scanning Electron Micrograph of C12BT aggregates. Particle sizes
were measured using the electron microscope. Overall average particle sizes
determined to be 1.787 µm.

Fig. 4.21 shows some isolated C12BT aggregates. This micrograph is a
good representation of the typical particle sizes detected with SEM. The average
diameter size of particles was determined to be 1787 nm. This is ~ 40% larger
than the 1300 nm effective diameter (Z-diameter) calculated by DLS. The smaller
particles are more difficult to focus in on using SEM, electron charging often
results, obscuring the image. For this reason, it is anticipated that many of the
smaller aggregates were not considered when measuring the particle sizes using
SEM. This would skew the average diameter to a size larger than it really is. The
use of sputter coating could have helped overcome the electron charging
impacting the imaging, however, instrumental limitations prevented this.
The phenylene-linked BTs also formed aggregates, despite being
considerably shorter in length. SEM images were collected for both the m-PhBT
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[meta-C6H4(L-Trp)2∙2HCl] and p-PhBT [para-C6H4(L-Trp)2∙2HCl], Fig. 4.22 and
Fig. 4.23.

4.431 µm

Figure 4.22 Scanning electron micrograph of m-PhBT aggregates.

The SEM images for the m-PhBT showed that fewer aggregates were
detected, Fig. 4.22. The distribution of the sizes of the aggregates detected was
more bimodal than those observed with C12BT. The aggregates were generally
large or small, with few in the 1000 - 3000 nm range. The m-PhBT aggregates
appeared to fuse together rather quickly, forming several very large structures,
and then leaving smaller aggregates that had yet to merge. Many aggregates,
estimated to be 500 nm or less were observed. The aggregates were mostly
spherical in shape although the integrity of the structures appeared to be
questionable. Instead of uniformly shaped spheres, the m-PhBT aggregates
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appeared to more irregular in shape. These aggregates showed fluidity, whereas
the C12BT aggregates resembled more rigid structures.

4.136

Figure 4.23 Scanning electron micrograph of p-PhBT aggregates.

The aggregates detected for the p-PhBT are larger than the aggregates
detected for the C12BT, Fig. 4.23.Unlike the m-PhBT, the aggregates of the pPhBT are greater in number and span a range of diameters. Clustering of the
aggregates can be seen, suggesting that aggregates fusing with one another
may be a more gradual process. In this case compared to the C12BT, the
particles seem to be approximately twice as large as the aggregates detected via
DLS. Attempts were made to capture images of smaller molecules; however, this
was not possible due to electron charging and the effect of the focused electron
beam on the sample.
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The SEM images show that the general shape of all the aggregates is
spherical. This would suggest that liposomes or micelles may be forming,
however this is purely speculative. The micrographs confirmed that aggregates
are being formed by both the aliphatic- and phenylene-linked BTs in the
micromolar range. The capability of the BTs to aggregate continues to coincide
with biological activity against bacteria observed in the MIC studies. C 12BT, mPhBT and p-PhBT formed aggregates and all three compounds have shown
some level of activity against bacteria in these studies. The size of the
aggregates forming in the PBS solution does not appear to be a determining
factor in the efficacy of the amphiphiles against the bacteria. The p-PhBT
appears to form some of the largest aggregates, however, is the least potent
(MIC = 128 µM) against E. coli (K-12) of the three compounds in this SEM study.
The C12BT showed the most potency in these MIC studies (MIC = 12 µM), yet it
forms the smallest aggregates of these three amphiphiles.
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4.5 Conclusion
Earlier work in the Gokel lab demonstrated that certain bis(tryptophan)
(BT) derivatives showed antimicrobial activity against a range of bacteria. The
genesis of this effort was the hypothesis that tryptophan would function as a
head group in the amphiphilic sense. If the molecules were amphiphiles, they
were likely to have an affinity for other membranes. It was well established that a
range of amphiphiles previously studied could insert into synthetic bilayers and
create ion channels. [5] [6] [19] This was documented by planar bilayer voltage
clamp experiments. Many of these compounds were found to function as
antibacterial agents. Of course, their potency and efficacy were dependent on
compound structure and organism. [20]
It was surmised that the effective amphiphiles inserted in the boundary
layers of bacteria, enhanced membrane permeability, which led to ion leakage.
These non-rectifying amphiphiles disrupted ion homeostasis, which in turn
affected the function of any enzyme that is ion regulated. Studies on other
amphiphiles developed in the lab showed that they disrupted the function of
efflux pumps. [6] To the extent that ejection of the antimicrobial amphiphile was
retained in the bacterium, it could have an additional deleterious effect.
At the outset of this project, several BTs had been prepared and surveyed
for biological activity. [7] [21] The present effort was to augment the series, to
determine if any additional biological activity was apparent, and to characterize
some of the physical properties of the BT amphiphiles. It was well understood
that what might be learned about membrane formation or membrane interactions
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by the BTs would not be directly applicable to the complex bacterial boundary
layers. However, correlations were sought between the physical and biological
findings that have proved to be revealing. In addition, the Gokel lab had
previously conducted a study in which the tryptophan was replaced with other
common amino acids. [7] None of these compounds showed any antimicrobial
activity. This further encouraged the present study.
The bacterial study for the BTs shows that all three of the newly
synthesized compounds were active against Gram-positive and Gram-negative
bacteria, at concentrations of 128 µM or lower. Fig. 4.24 shows a graph of the
biological data over the series of BTs having alkylene spacers. These
compounds are Cl¯+H3N-Trp-(CH2)n-Trp-NH3+Cl¯ in which the number of
methylene groups is 3, 4, 6, 8, 10, 12, and 14. What is clear from the graph is
that E. coli (K-12) and methicillin resistant S. aureus (MRSA) respond to the BTs
in a similar way, which multidrug resistant E. coli does not. There are two key
findings here. First, extension of the alkylene spacer from dodecylene to
tetradecylene further enhanced the antimicrobial potencies against E. coli (K-12)
and MRSA. This is a positive finding. Second, the behavior of MDR E. coli is
significantly different and it is clear that none of the BTs would be useful against
it. Note that the highest values for each organism are artificially limited to 128
µM, a value that indicates no significant activity. In some cases, the values
measured were much higher, but their inclusion in the graph would make the
trends less discernable.
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Figure 4.24 Graph comparing the change in MIC of the aliphatic BTs
against E. coli (K-12), MRSA and MDR E. coli as the alkylene chain
length is increased.

The biological data from which the graph of Fig. 4.24 are included in
Table 4.1. Note that the table actually includes two classes of BTs: those having
alkylene spacers and those having arylene linkers. These two groups are not
thought necessarily to be directly comparable. More is known about the latter, so
they are included as controls.
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Table 4.1 Summary of the biological activity and aggregation of BTs
MIC (µM)
Compound

E. coli

MRSA

(K-12)

Aggregation

Max Z-

MDR E.

1st Observed

diameter

Coli

(µM)

@ 128 µM

clogP

C3BT

>128

>128

>128

N/A

N/A

1.07

C4BT

>128

>128

>128

N/A

N/A

1.59

C6BT

>128

>128

>128

N/A

N/A

2.48

C8BT

128

32-64

32-64

32

2700 nm

3.37

C10BT

32-64

16

64-128

8

1500 nm

4.26

C12BT

8-16

4-8

>128

8

1300 nm

5.15

C14BT

8

≤4

>128

8

1600 nm

6.04

m-PhBT

64

--

--

≤128

1300 nm

3.25

p-PhBT

128

--

--

≤128

800 nm

3.25

Several apparent correlations stand out. First, no biological activity is
observed against the three organisms listed for C3BT, C4BT, and C6BT. In all
cases, no biological activity was observed up to 128 µM. Because the linker
chains are short, it might be expected that amphiphilic behavior is unlikely.
Indeed, dynamic light scattering (DLS) shows that no aggregates form from this
group of compounds. The inference that we draw from this is that amphiphilic
character is required for the compounds to interact with either the Gram-positive
or Gram-negative boundary layers of the bacteria.
The scanning electron microscopy (SEM) studies confirmed that
organized assemblies are formed by the C12BT and arylene-linked BTs. They
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confirm that the aggregates are spherical, presumably liposomal, and of a size
comparable to those detected by DLS. Neither the DLS nor the SEM studies
provide further information in regard to the complex membrane structure of
bacterial cells.
An additional correlation is found in the hydrophobicity index clogP. The
calculated distribution constants for C3BT, C4BT, and C6BT are all below 3. C8BT
and the phenylene compounds have clogP values close to, but above, 3 and
show biological activity. However, the phenylene compounds bear a structural
resemblance to the well-known tris(arene) structures prepared by Crabtree and
coworkers. [22] In a previous study conducted in the Gokel lab, it was shown that
the Crabtree compound was a chloride complexing agent. [23] Complexation of
chloride could disrupt ion homeostasis. Rather than functioning as an amphiphile,
the arenyl BTs could be functioning as ion complexing carriers in the bacterial
membranes. A comparison of the Crabtree structure and m-PhBT are shown in
the figure below (Fig. 4.25).

Figure 4.25 Structures of the Gokel lab compound m-PhBT (left) and
the Crabtree tris(arene) compound (right)
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The longer chain BTs (C10BT – C14BT) have clogP values above 4. The
values represent the increased hydrophobic character due to the longer aliphatic
chains. The added hydrophobicity and resulting amphiphilic character of the BTs
is thought to be important for aggregation and activity with the Gram-positive and
Gram-negative boundary layers.
Notwithstanding the differences in membrane structure found in Gramnegative or Gram-positive bacteria, amphiphiles comprise part of either’s
boundary layer. The ability of BTs to form aggregates was expected to give an
indication of their affinity for other amphiphilic membrane systems. To the extent
a bacterial membrane interaction with BTs is suggested by the aggregation data,
the inference is that some structural influence on the membrane would occur.
Any disorganization or disruption of a bacterial membrane is likely to enhance the
penetration of the BT or other exogenous material.
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4.6 Experimental Details
4.6.1 Dynamic Light Scattering (DLS). Measurements were performed on
a Brookhaven Instruments Corp. ZetaPALS instrument at 25 °C using a 660 nm
laser and correlating scattering at 90°. Samples were prepared by dissolving
bis(tryptophan) amphiphile in DMSO and adding a 15 µL aliquot to 2985 µL of
solvent (PBS solution, 18.2 MΩ H2O or MHII media) to maintain a 0.5% (v/v)
DMSO concentration. The sample was added to a clean quartz cuvette and
equilibrated in the instrument for 5 min at 25 °C. Ten measurements were made
on each sample at equal time intervals, depending on the total time of the
experiment (24 mins for 4-hour experiments, 6 minutes for 1-hour experiments).
The average effective diameter (Z-diameter) was calculated and reported.
Cleaning of cuvettes included initial overnight soaking in 2 M HNO3, wash with
95% ethanol (x 3), deionized water (x 3) and rinse with appropriate solvent (e.g.,
PBS solution). Solutions are prepared and used immediately or stored in a clean
vial and capped to avoid contamination and dust particles. The dust-filter option
on the instrument is also applied for all experiments as the instrument is sensitive
to dust particles.

4.6.2 Scanning Electron Microscopy (SEM). Measurements were
performed on a Thermo Fisher Scientific Apreo 2 C SEM instrument at 25 °C
using the Trinity Detection System. Samples prepared for DLS were also used
for SEM imaging. The samples were adhered to conductive carbon fiber
adhesive tape and allowed to dry. Samples were mounted on the Eucentric
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goniometer stage before being placed under vacuum in the instrument for
analysis to proceed. The voltage range of the electron beam was 200 V – 30 kV
and the current range was 1 pA – 50 nA.
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